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ABSTRACT 
Protein-surface interactions, no matter structured or unstructured, are 
important in both biological and man-made systems. Unstructured interactions are 
more difficult to study with conventional techniques due to the lack of a specific 
binding structure. In this dissertation, a novel approach is employed to study the 
unstructured interactions between proteins and heterogonous surfaces, by looking 
at a large number of different binding partners at surfaces and using the binding 
information to understand the chemistry of binding. In this regard, surface-bound 
peptide arrays are used as a model for the study. Specifically, in Chapter 2, the 
effects of charge, hydrophobicity and length of surface-bound peptides on binding 
affinity for specific globular proteins (β-galactosidase and α1-antitrypsin) and 
relative binding of different proteins were examined with LC Sciences peptide 
array platform. While the general charge and hydrophobicity of the peptides are 
certainly important, more surprising is that β-galactosidase affinity for the surface 
does not simply increase with the length of the peptide. Another interesting 
observation that leads to the next part of the study is that even very short surface-
bound peptides can have both strong and selective interactions with proteins. 
Hence, in Chapter 3, selected tetrapeptide sequences with known binding 
characteristics to β-galactosidase are used as building blocks to create longer 
sequences to see if the binding function can be added together. The conclusion is 
that while adding two component sequences together can either greatly increase 
or decrease overall binding and specificity, the contribution to the binding affinity 
and specificity of the individual binding components is strongly dependent on 
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their position in the peptide. Finally, in Chapter 4, another array platform is 
utilized to overcome the limitations associated with LC Sciences. It is found that 
effects of peptide sequence properties on IgG binding with HealthTell array are 
quiet similar to what was observed with β-galactosidase on LC Science array 
surface. In summary, the approach presented in this dissertation can provide 
binding information for both structured and unstructured interactions taking place 
at complex surfaces and has the potential to help develop surfaces covered with 
specific short peptide sequences with relatively specific protein interaction 
profiles. 
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CHAPTER 1: GENERAL INTRODUCTION AND BACKGROUND 
INFORMATION 
Protein-Surface Interactions 
Protein-surface interactions are important in both biological and artificial 
systems[1]. Biological systems are organized by complex networks of molecular 
interactions with dynamic behavior, and proteins are one of the key components in such 
networks[2, 3]. The cell surface is one of the most common interfaces in biological 
systems. Some examples of biological processes involving proteins interacting with 
molecular components on cell surfaces include cell adhesion[4], cell-cell interactions[5], 
hormone cellular signaling pathways[6] and information/nutrient exchange. Artificial 
systems are usually designed and synthesized to mimic the functional properties of 
biological systems to achieve similar or even better results with manufacturing 
advantages. Interactions between proteins and synthetic material surfaces are important in 
developing and manipulating artificial systems[7]. For example, medical implants and 
artificial tissues developed to help patients regain body function are exposed to proteins 
and interact with them to trigger defined biological reactions[8]; biomolecular functional 
units such as enzymes, receptors and antibodies are utilized in various types of biosensor 
and bioelectronics to increase device performance[9]; DNA, peptide and protein based 
diagnostic and sensor arrays that incorporate protein functions are used clinically and/or 
at the research level in biomedical industries and academia[10, 11].   
Specific versus Nonspecific Interactions 
The interactions governing biological processes can be sorted into two general 
categories: specific interactions and nonspecific interactions. Specific interactions are 
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normally associated with well-defined recognition/binding structures and high free 
energy changes upon binding[12]. Some examples of specific interactions in nature 
include DNA-protein bindings, antigen-antibody interactions, protein-ligand bindings and 
enzyme-substrates complexes. Specific interactions are usually well-studied and more 
thoroughly researched in comparison to nonspecific interactions. In contrast, nonspecific 
interactions generally lack a unique structure for the final complex formed, and for this 
reason, they may also be referred to as unstructured interactions. Although the term 
“nonspecific” may refer to a weak interaction that is universal to all interacting 
molecules, in some cases, the situation is not that simple. Some nonspecific interactions 
can greatly favor some protein interactions over others and they can contribute 
significantly to the overall binding affinity.  In fact in many cases, many kinds of 
interactions can take place at the complex binding surfaces of proteins and the strength of 
an interaction largely comes from nonspecific interactions such as general charge-charge 
interactions. The nonspecific interactions result in a set of shallow potential wells on the 
potential energy surface with multiple possible unstable interacting complexes. What 
makes a reaction specific is that a certain metastable structure could be formed by aid of 
specific short-range forces, which can make one potential well deep enough so that it is 
the one predominantly occupied.  Hence, the concepts of specific and nonspecific 
interactions are better thought of as two ends of a more continuous spectrum.  
Importance of Nonspecific Interactions 
Nonspecific interactions, or unstructured interactions, are driven by some 
combination of general weak interactions including electrostatic interactions, 
hydrophobic interactions (entropic effects) and hydrogen bonding interactions (dipolar 
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interactions). They are themselves the sum of a variety interactions that do not stabilize 
one particular structure. In the crowded cellular environment, the majority of interactions 
proteins may have with each other or with the surfaces of cells are nonspecific. If one 
only considers protein-protein interactions, roughly, for a cell with N proteins, there are 
on the order of N specific protein-protein interactions, but almost N2 nonspecific protein-
protein interactions[13]. Although these nonspecific interactions are ubiquitous in 
biology, they are generally poorly studied in terms of their role in biology and thus there 
is a lack of fundamental understanding of their chemical and structural nature. Many 
biological processes cannot function properly without the participation of nonspecific 
interactions.  In fact, in many cases, the distinction between “specific” and “nonspecific” 
interactions is not clear cut. For example, the interaction between a DNA-binding protein 
(i.e. RNA polymerase, endonuclease and methyltransferase) and its target DNA is 
initially a nonspecific (or sequence-independent) interaction at a random DNA site. This 
interaction helps the DNA-binding protein find its specific binding site rapidly and 
efficiently by “facilitated diffusion”.  It can then initiate sequence-dependent interactions 
at the correct binding location. The initial interaction is considered as a nonspecific 
interaction because it is not associated with a particular DNA sequence; however, it is 
quiet specific to double stranded, B-form DNA in general and is an important 
intermediate step in the process of sequence-dependent DNA recognition and binding[14, 
15].  
In an extraordinary crowded cellular environment, it is very important that a 
protein not only specifically bind to its target molecules, but also selectively not adsorb to 
other non-target molecules. The failure of protein to maintain a strong specificity to its 
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functional partners can result in protein misfolding and aggregation, which may lead to a 
variety of diseases including neurodegenerative diseases such as Parkinson’s disease[16] 
and Alzheimer's disease[13, 17].  In this regard, a better understanding of how proteins 
interact with non-target molecules is the key to understanding how proteins remain stable 
and avoid aggregation in complex environment. 
Nonspecific or unstructured interactions between proteins and complex surfaces 
are of particular significance to our understanding of fundamental biology and 
development of related applications. A protein interacting with surface bound molecules 
differs from its interaction with its binding partner in solution, where one protein only 
interacts with one binding partner. Due to the high local concentration, a protein may 
interact with multiple molecules or parts of a molecule on a surface. Thus, the interaction 
between a protein and surface bound molecules can be considered as one surface 
interacting with another. Nature uses selective, unstructured interactions between protein 
surfaces and complex surfaces in their surroundings to its advantage and mimicking that 
kind of selectivity is important in developing biomaterials or biosensors with surfaces 
that avoid background binding and interference, but facilitate selected interactions[18, 
19]. Another application of utilizing unstructured interactions between proteins and 
complex surfaces is the immunosignature technology developed in the Center for 
Innovation in Medicine in the Biodesign Institute at Arizona State University. In that 
case, a surface covered with relatively short peptides is used to discriminate between the 
binding profile of antibodies in the serum of healthy individuals and people with specific 
diseases. The general characteristics of a surface can result in very large discrimination 
between binding partners, even without forming specific binding structures[20].  
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Analytical Difficulties in Characterizing Nonspecific Interactions  
A large number of methods have been developed to study interactions between 
proteins and their binding partners, either in solution or at surface [21-25]. Table 1.1 
shows selected examples of different genetic, biochemical and biophysical methods for 
analyzing protein interactions. However, most methods focus on identifying and/or 
characterizing specific interactions rather than nonspecific interactions. In fact, most 
nonspecific interactions are generally considered as noise in experiments. The reason 
they are a problem in terms of noise is that they are not that low in total.  The issue is that 
particular structures are formed with low affinity, but there are many possible structures.  
Most techniques listed below in Table 1.1, including crystallography, 
immunoprecipitation, phage display and affinity chromatography, force the system to 
search for the most favored single structure, which is defined by specific interactions. 
Techniques like NMR only show the specific interactions because the rest average out to 
zero given the highly specific signals. For either technique used, a very nonlinear process 
that strongly favors one specific interaction is imposed during the study.  
Table 1.1. Selected Examples of Different Methods Studying Protein Interactions [21-25] 
Method Description 
Living Cell 
Assay 
Co-immunoprecipitation 
Identify protein-protein interactions with a 
specific antibody 
In-vitro 
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Affinity purification–MS 
Isolate interacting protein targets with 
affinity chromatography and identify with 
MS analysis subsequently 
In-vitro 
Yeast two hybrid system 
Screen interactions between fusion 
proteins inside the nucleus of yeast and 
identify binding partners of a protein 
In-vivo 
DNA/protein/peptide     
microarrays 
Screen and identify interactions between 
molecules 
In-vitro 
Phage display, RNA 
display 
High-throughput screening of protein 
interactions 
In-vitro 
Synthetic lethality 
Genetic method for verify protein 
interactions 
In-vivo 
X-ray crystallography, 
NMR spectroscopy 
Structural study for interactions with 
specific binding structure 
In-vitro 
Fluorescence resonance 
energy transfer (FRET) 
Biological characterization for interactions 
between single molecules 
In-vivo 
Surface plasmon 
resonance (SPR) 
Characterize kinetic constant for binding 
processes 
In-vitro 
Electron microscopy Structural and biological characterization In-vitro 
Moreover, there are many techniques intentionally designed to eliminate 
nonspecific interactions. Examples include affinity purification methods such as tandem 
affinity purification (TAP) and “large library” selection approaches such as phage 
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display. Affinity purification methods are generally biased toward proteins with high 
affinity and slow kinetics of dissociation[22]. TAP method is a type of affinity 
purification using a TAP tag and two purification steps (Figure 1.1)[26, 27]. In 
combination with mass-spectroscopy, it can identify interacting partners with high 
affinity[27]. Weakly interacting partners without a stable binding structure are easily lost 
during the series of purification steps[22, 28] and thus it is not suitable for identifying 
nonspecific/unstructured binding partners.  
“Large library” selection approaches are widely used for the selection of affinity 
reagents.  Figure 1.2 shows the general scheme for in vitro biological selection 
approaches. Just like the natural selection process, a selection pressure is applied to the 
large library of random molecules. Molecules that successfully pass the selection process 
will be amplified for further analysis or served as the library for the next selection cycle 
and molecules failed to pass will be left out. Many approaches can be used to generate 
the desired libraries with capability of selection and amplification. For example, a 
random double stranded DNA pool can be directly synthesized with a DNA synthesizer 
and amplified through PCR; a single stranded DNA/RNA pool can be separated and 
transcribed from a double stranded DNA pool and amplified through reverse transcription 
and PCR[29]; peptide and proteins can be linked to their coding sequences and amplified 
through these sequences by molecular display techniques such as phage display, mRNA 
display and ribosome display[30-34]. These types of approaches may be great for 
identifying affinity reagents but they cannot serve as a tool to systematically study 
nonspecific interactions because the identity of the molecules in the library remain 
unknown until the end of the selection cycles and information about moderate or weak 
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interactions, which is critical for understanding general rules governing nonspecific 
interactions, is permanently lost. The use of chemical selection systems is another way to 
create large libraries for selection of desired molecules, especially for peptides[33]. The 
difference between chemical selection and in vitro biological selection is that the 
component cannot be easily amplified and reselected after the selection. Although 
chemical selection systems are very effective in creating large libraries that contain large 
number of nonspecific/unstructured binding candidates, only a few candidates survive the 
screening protocol and reach the final characterization step, which is required to obtain 
the candidate identity.   
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Figure 1.1. Schematic representation of TAP tags and the TAP purification 
strategy[27].   
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Figure 1.2. General scheme for in vitro selection approaches 
Another difficulty in characterizing nonspecific interactions results from their 
lack of particular stable structures. For interactions that result in formation of a specific 
structure, conventional biophysical approaches such as X-ray crystallography, NMR 
spectroscopy and electron microscopy can be employed to characterize the structure of 
the complex and then that structural information can be used to understand the 
mechanism of these interactions. These approaches cannot be applied to the study of 
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nonspecific interactions because the binding complexes resulting in nonspecific 
interactions do not form a single final structure.   
Approaches for Studying Nonspecific Interactions 
A limited number of approaches have been developed to study nonspecific 
interactions. One chemical way to identify nonspecific protein interactions is using cross-
linking reagents such as formaldehyde to crosslink molecules in close vicinity to the 
target protein[35, 36].  Although chemical crosslinking can help identify interactions that 
do not form stable binding structures, it can also result in complexes with molecules that 
are not in direct contact with the target protein, as long as they are in close proximity[23]. 
Bioinformatics methods have been used by Jiang’s group at University of Washington to 
separate nonspecific effects from the many specific functions of proteins and further 
study the nonspecific interactions in molecular chaperones[18, 19]. There they define 
nonspecific interactions as interactions that lack specific protein functions. DNA and 
peptide microarrays allow high-throughput screening of compounds for affinity reagents 
and exploration of the diversity of interactions between proteins and surface bound 
molecules. Ordered array-based molecular interaction measurements have the advantage 
that one measures all strengths of interactions, rather than just seeing the strongest binder. 
Both DNA and peptide microarrays present a set of sequences with great chemical 
complexity that can be precisely controlled. Peptide microarrays, in particular, have great 
potential because the broad chemical diversity that can be represented in relatively 
modest length peptide sequences[37].  
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Different Peptide Microarray Platforms 
Surface-bound peptide arrays can serve as a great model to explore the range of 
protein-surface interactions and to better understand the kinds of unstructured interactions 
that take place at chemically complex surfaces. Peptide arrays consist of immobilized 
peptides spatially addressed on substrates such as glass or silicon surfaces. They possess 
several advantages in protein-surface interactions research: (1) peptides are short 
fragments of protein molecules, which are key surface components of biological 
interfaces; (2) short peptides are relatively easy to make by chemical synthesis; (3) 
synthesis is not limited to using only the 20 naturally occurring amino acids; (4) modest 
size peptide libraries can present high chemical complexity and can be arranged in an 
addressable format; (5) Interactions can be studied systematically as interacting events 
between all binding partners, weak or strong, will be revealed.  Currently, there are two 
major ways to prepare peptides on surfaces. One is pre-synthesizing functionalized 
peptides and then covalently immobilizing them to the surface via linker molecules; and 
the other one is in situ synthesis of peptide microarrays[38, 39].  
There are several peptide immobilization approaches available to attach pre-
synthesized peptides to surface. For example, peptides can be synthesized with a C-
terminal linker containing a cysteine and covalently attached to a sulfo-SMCC treated 
surface via disulfide bond[40, 41]. This immobilization strategy has been employed by 
researchers at Center of Innovation in Medicine in Biodesign Institute at ASU to 
synthesize CIM10K peptide arrays, which has been used in several different applications 
including immunosignaturing and ligand discovery.  
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Some commercially available peptide arrays are synthesized by a variety of in-
situ peptide synthesis approaches including SPOT synthesis, light-directed synthesis and 
particle-based synthesis. The SPOT synthesis technology delivers C-terminally activated 
amino acid derivatives and reactions reagents within liquid droplets onto defined areas at 
surface. Usually, a standard Fmoc solid phase peptide synthesis reaction is followed to 
couple these amino acid building blocks to surface[42]. SPOT technology based synthesis 
can be performed either manually or automatically and it is by far the most common and 
frequently used method for in situ synthesis of peptide arrays[39]. Particle-based 
synthesis is commercialized and utilized by PEPperPRINT to fabricate their 
PEPperCHIP. In this method, Fmoc-amino acids with C-terminal OPfp-ester activation 
group are embedded within a solid microparticle and printed onto the surface with a 
custom 24-color laser printer. This is followed by simultaneous particle melting, which 
releases the amino acids and enables the coupling reactions. As in conventional Fmoc 
solid phase synthesis, a cycle of synthesis is finished after washing off excessive 
materials and Fmoc deprotection[42]. The idea of light-directed peptide array synthesis, 
which utilizes photolabile protected amino acids and lithographic masks, was brought up 
by Fodor et al. in 1991[43]. The original technology requires the use of photolabile 
protecting groups, which did not perform well in term of repetitive coupling yield when 
compare to the conventional t-boc or Fmoc protecting groups, for a long time[42].  A 
couple of variant photolithographic synthesis methods were developed to overcome this 
problem by using photo acids to deprotect conventional t-boc protected amino acids at 
the designated positions that are exposed to light. However, these techniques are still 
associated with large numbers of peptide-specific coupling cycles as only one single kind 
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of amino acid can be coupled at a time. Two commercially available peptide array 
platforms are used in the work presented in subsequent chapters and the platforms will be 
discussed below.  
LC Sciences PepArray™ 
A type of photolithographic technique utilizing photogenerated acids (PGA), 
digital photolithographic masks and conventional t-boc solid phase synthesis has been 
commercialized by LC Sciences to produce PepArray™, which is used in chapter 2 and 
chapter 3 to explore the nature of unstructured interactions between proteins and surface 
bound peptides. The technique was developed based on proprietary µParaflo® 
microfluidics technology, which allows direct synthesis of peptides on a high density 
microfluidic chip as features in specific locations on the chip using a PGA to deprotect 
the t-boc protected amines of nascent peptides[44, 45]. Peptide libraries synthesized on 
the chips are made to order and can be completely customized. Figure 1.3 shows the 
ordering process of LC Science PepArray chips. Two formats of chips are available 
through LC Sciences, 4000 or 30,000 features on arrays with ~1.5cm2 surface area.  The 
chip is actually an enclosed microfluidic system, which contains fluid distribution 
channels and picoliter scale reaction chambers with physical isolation from each other 
(Figure 1.4)[44]. Each chamber contains one specific peptide sequence. The in-situ 
peptide synthesis consists of the following steps (Figure 1.5): (1) derivatizing the surface 
with a protected NH2-linker, with a density on the surface of less than 1pmol per 1mm
2 
area; (2) applying a solution of the PGA precursor (PGA-P) in dichloromethane; (3) 
deprotecting the protected amine in the desired reaction chamber with digital 
photolithographic masks, (4) coupling the amino acid, capping any unreacted linkers and 
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deprotecting the side chain using standard peptide synthesis procedure, (5) repeat step 2, 
3 and 4 until all amino acids to be incorporated is added for coupling[45-48].   
 
Figure 1.3. Flowchart of LC Science PepArray process. The red square indicates which 
steps were performed by LC Sciences. 
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Figure 1.4. LC Science PepArray™ microfluidic system with fluid channels and reaction 
chambers[44].  
 
Figure 1.5. In situ peptide synthesis on the PepArray surface[44, 49]. 
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HealthTell 330K Peptide Array 
Another photolithographic mask-based patterned synthesis for peptide array 
production was developed and commercialized by HealthTell to fabricate very high 
density peptide arrays. Thus far, there are two types of peptide libraries available for the 
HealthTell arrays, one with ~330,000 peptide features on the array surface and the other 
with ~350,000. The work present in Chapter 4 utilizes the format of 330K peptide array 
to study the fundamental questions about unstructured interactions between 
immunoglobulins and complex, peptide covered surfaces. These 330K HealthTell peptide 
arrays consist of ~330,000 peptide sequences with an average length of ~12 amino acids 
(plus a three amino acid linker, GSG) and a length range from 3 to 17 amino acids. 
Sixteen of the twenty natural amino acids were used in the synthesis (cysteine, 
methionine, isoleucine and threonine were excluded).  The ~330,000 feature array covers 
an area of ~0.5 cm2 and each feature is 8 microns in diameter and contains a different 
peptide sequence.  The peptide sequences were generated using a pseudo-random 
algorithm designed to minimize the number of synthesis steps while sampling 
combinatorial sequence space fairly evenly. The procedure for synthesis of the HealthTell 
peptide arrays is described below. First, Boc-glycine is uniformly attached to the thermal 
oxide-coated silicon wafer surface derivitized with monolayer of amnio silane; second, a 
photoresist with photoacid generator is spun onto the wafer surface and exposed through 
a mask to 365nm light; third, Boc-protected amines are deprotected at desired feature 
locations according to the pattern of the mask used; and last, a coupling solution with an 
amino acid is spun onto the wafer surface and the coupling reaction takes place at the 
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deprotected features. The process is repeated to create the desired peptide sequences at 
each feature (adapted from a procedure from Legutki et al., in press).  
Proteins Used in the Experiments 
A few individual proteins, including β-galactosidase, α-1 antitrypsin and 
immunoglobulins, as well as mixtures of protein and serum have been used in the next 
three chapters of this thesis to profile the interactions between proteins and surface bound 
peptides. An overview of these proteins and their known binding partners is presented 
below.   
β-Galactosidase: Function, Structure and Modulation 
-galactosidase is a well-studied enzyme that catalyzes hydrolysis of lactose and 
other -galactosides into monosaccharides[50]. It is encoded by the LacZ gene, which is 
one of the three adjacent genes in the lac operon model developed by Jacob and 
Monod[51]. E.coli -galactosidase is a tetramer with four identical polypeptide chains, 
each of 1023 amino acids[52]. Each monomer is composed of five domains and domain 3 
has an α/β or ‘TIM’ barrel structure with the active site located at the C-terminal end of 
the barrel (Figure 1.6)[50, 53, 54]. Furthermore, it has been found that certain residues 
near amino-terminal contribute significantly to the function of the active site by 
stabilizing each of the dimers in the overall tetrameric structure[55, 56]. This 
phenomenon, known as α-complementation, is critical to maintain the enzyme activity 
and served as the basis for the common blue/white screening (with X-gal) used in 
cloning[57].  
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Figure 1.6. The backbone structure of the β-galactosidase tetramer[50, 54]. Coloring is 
by domain: complementation peptide, orange; Domain 1, blue; Domain 2, green; Domain 
3, yellow; Domain 4, cyan; Domain 5, red. Lighter and darker shades of a given color are 
used to distinguish the same domain in different subunits. The metal cations in each of 
the four active sites are shown as spheres: Na+, green; Mg2+, blue[50]. 
It has been long known that the enzymatic activity of β-galactosidase can be 
either activated or inhibited through interactions with antibodies[58, 59]. A more recent 
study conducted by Fu et.al showed that the enzymatic activity can also be regulated by 
relatively short peptides[60, 61].  Proteolytic mapping of peptide binding to tetrameric β-
galactosidase showed that the binding region is located at the activating interface[61].  
α1-Antitrypsin: A Serine Protease Inhibitor (Serpin)  
α1- antitrypsin is a plasma glycoprotein that belongs to serpin (serine protease 
inhibitor) superfamily. It is the major physiologic inhibitor of human neutrophil elastase, 
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which can break down elastin, a major contributor to the elasticity of the lungs[62]. α1-
antitrypsin deficiency, which causes chronic obstructive pulmonary disease (COPD) and 
chronic liver disease,  is a genetic disorder that is caused by a variety of mutations (i.e. S 
mutant (Glu264Val), Z mutant (Glu342Lys))  in the gene encoding the protein[63]. The 
mature α1-antitripsin protein in human plasma is a 394 amino acids monomer with 
carbohydrate side chains linked to the protein via asparagine[62, 64].  It consists of nine 
α-helices (A–I), three β-pleated sheets (A, B and C), and a mobile reactive center loop, 
which can be cleaved and inserted into the β-pleated sheet A when it interacts with the 
target proteases[65-67] (Figure 1.7). The reactive center loop in the Z mutant of one α1- 
antitrypsin can interact with β-sheet A in a second due to the aberrant opening of the β-
sheet A resulting from the Glu342Lys mutation at the end of the reactive loop and the top 
of the strand 5 of β-sheet A[68, 69]. This can cause an abnormal loop-sheet 
polymerization in α1-antitrypsin and a polymer of α1-antitrypsin will form and 
accumulate in the hepatocyte and lead to a plasma deficiency[70, 71].    
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Figure 1.7. Formation of the α1-antitrypsin-trypsin complex[65]. Red, α1-antitrypsin β-
sheet A; yellow, mobile reactive center loop.  
 A number of synthetic peptides have been found to bind to the mutant form of α1-
antitrypsin to stop the polymerization[69]. This involves the binding of the reactive 
center loop analogue peptides to the loop insertion site in β-sheet A. Polymerization may 
be blocked because the space for insertion is filled with the synthetic peptide. A 6-mer 
reactive loop peptide (FLGAIG) has demonstrated high specificity and affinity to Z α1-
antitrypsin and other similar peptides (i.e. FLAAIG, FLEAAG, FLAA, TTAI etc) were 
later confirmed possessing similar binding propensity[71-73]. Another way to prevent 
polymerization is to fill the cavity, a surface hydrophobic pocket which is present in the 
native α1-antitrypsin but filled when the β-sheet A accepts a reactive loop peptide during 
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polymerization[67, 69]. While the space-filling mutation has demonstrated the possibility 
of blocking polymerization, there is no effective synthetic peptide that mimics this 
effect[66].  
Antibodies: Monoclonal Antibody and Serum 
Antibodies are “Y”shaped protein molecules produced by plasma B-cells to 
identify and bind foreign objects. They are produced when anything recognized as 
foreign is found by the immune system. There are five classes of antibodies: 
Immunoglobulin G (IgG), IgM, IgA, IgD, and IgE. These immunoglobulins, or 
antibodies, all have the basic four-chain antibody structure, which is composed of two 
identical heavy chains and two identical light chains[74]. The antibody structure contains 
two antigen-binding (Fab) regions, which help the binding of antibody to antigen, and 
one Fc region, which mediates interaction with effector molecules[74]. The class of 
antibody is determined by its heavy chain while all classes have the same light chains. 
Light chains are composed of one constant domain and one variable domain, whereas 
heavy chains have either three or four constant domains and one variable domain. The 
variable domains of heavy and light chains form the antigen-binding site, which is 
located at the tip of the Fab regions[75].  
Monoclonal antibodies are commercially available monospecific antibodies that 
are produced by a clonal cell line and that bind to a specific epitope. They are good 
affinity reagents, which are useful in developing tools in therapy, diagnostics and 
purification. It is well known that monoclonal antibodies bind their cognate sequences 
with high affinity and specificity; however, some recent studies have shown that they can 
also have strong and unique interactions with noncognate peptide sequences[20, 76, 77].    
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Serum from blood contains a heterogeneous mixture of many biomolecules 
including a large diversity of different antibodies. The major type of antibody in the 
serum is IgG. Serum is used in many diagnostic tests to detect different type of diseases 
including infectious diseases and cancer. A novel approach, an immunosignature, utilizes 
peptide microarrays to profile the humoral immune response by monitoring the 
interaction between serum and a large array of surface bound peptides[41]. It is clear that 
serum from people with certain diseases present different binding patterns in comparison 
with the binding patterns observed in healthy individuals.  
Project Overview 
In this dissertation, surface-bound peptide microarrays are used as a model to 
explore the range of protein-peptide interactions that take place at chemically complex 
surfaces. A new approach for studying interactions between protein and surface bound 
peptides is described and utilized in the subsequent chapters. The approach is statistical, 
simply looking at a large number of different potential binding partners on surfaces and 
using that to understand the chemistry of binding between proteins and chemically 
complex surfaces. Chapter 2 addresses how proteins behave on the arrays and to what 
extent proteins bind to the short random-sequence peptides made using a subset of 7 
amino acids out of 20 natural amino acids at surfaces. The effect of charge, 
hydrophobicity and length of surface-bound peptides on surface affinity of β-
galactosidase and α1-antitrypsin and the degree of differential binding will be discussed 
in detail. Chapter 3 tests a set of hypotheses of practical importance in the development 
of complex surfaces that interact with individual proteins (β-galactosidase as an example) 
and protein mixtures. These hypotheses center around fundamental questions of to what 
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extent the properties of short peptide sequences can be added together to create longer 
sequences with composite binding function and how one might build such surfaces from 
smaller components of known binding characteristics. Chapter 4 addresses how 
monoclonal antibodies and serum interact with diverse-sequence peptides on the surface 
of high density peptide arrays. How the affinity of monoclonal antibodies and serum to 
surface-bound peptides correlate with the physical properties of such peptides will be 
discussed in detail.  
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CHAPTER 2: SELECTIVE PROTEIN-PEPTIDE INTERACTIONS AT 
SURFACES 
ABSTRACT 
Protein-surface interactions are of critical significance in both biological and man-
made systems. While the term “specific binding” is normally reserved for the description 
of well-structured interactions, it is often the case in biology that there are unstructured 
interactions that greatly favor some protein interactions over others, a necessity in the 
highly crowded environment of the cell. In this study, surface-bound peptide-arrays were 
used as a model to explore the range of protein-surface interactions and to better 
understand the kinds of “nonspecific” or unstructured interactions that take place at 
chemically complex surfaces.  Three samples, β-galactosidase, α1-antitrypsin and a 
mixture of 9 different proteins, were bound to arrays of nearly 5000 different peptides 
with a wide range of hydrophobicity, charge and peptide length. All three protein samples 
show higher binding affinity to positively charged peptides.  While β-galactosidase binds 
poorly to very hydrophobic peptides, either in terms of absolute binding or relative to the 
mixture of proteins, α1-antitrypsin binds with higher affinity to more hydrophobic 
peptides. More surprising is the observation that β-galactosidase affinity for the surface 
does not simply increase with the length of the peptide, as one might expect, even when 
only the best binders are considered.  Instead, its affinity (both absolute and relative to 
the protein mixture) peaks in the 4-9 amino acid residue range and then decreases 
substantially by 12 amino acids. In contrast, α1-antitrypsin increases nearly 
monotonically with peptide length, both in terms of apparent affinity and binding relative 
to other proteins. Of particular significance in a practical sense, it was possible to obtain 
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quite specific binding; the identity of the 100 peptides that showed the best apparent 
affinity for each of the three protein samples overlapped very little.  Thus, using this 
approach it would be straightforward to develop surfaces covered with specific short 
peptide sequences with relatively specific protein interaction profiles. This work has been 
published on Acta Biomaterialia. Wang W, Woodbury NW. Selective protein-peptide 
interactions at surfaces. Acta Biomater 2014;10:761-8.  
INTRODUCTION 
The interaction between proteins and chemically heterogeneous surfaces is 
important in both biological and man-made systems[1]. Cell surfaces are involved in 
myriad activities in which proteins in solution interact with cellular components 
including cell-cell interactions, cell-surface adhesion, protein hormone sensing and 
exchange of nutrients or other small molecules that are carried by proteins.  The need to 
avoid nonspecific binding of proteins to surfaces and other proteins in this environment 
likely limits the total number and surface properties of proteins in the cell[2].  
Interactions between proteins and man-made material surfaces have become increasingly 
important in the development of implants, artificial tissues, and diagnostic assays, as well 
as in the incorporation of protein functions (e.g. enzymes, antibodies) in a variety of 
commercial products and devices[1, 3].  In this regard, some fundamental questions 
remain unanswered about the relationship between the structural nature and complexity 
of molecules on surfaces and their interactions with proteins.  The concept of avidity, 
interactions between multiple closely spaced ligands on a surface and a protein, is not 
well understood in terms of the various kinds of interactions that take place and the 
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interplay between general chemical properties such as charge and hydrophobicity vs. 
structurally dependent interactions. 
Affinity between a surface and a complex biological sample is often thought of in 
terms of specific and nonspecific interactions.  The specific interactions are normally 
described in terms of well-defined, uniform contacts that result in a particular structure 
for the final complex formed.  Non-specific interactions generally do not result in a 
unique structure for the complex, but instead are driven some combination of general 
interactions (e.g., charge, hydrophobicity) and a multiplicity of structurally dependent 
weak interactions between particular groups. However, non-specific interactions are not 
always non-selective or necessarily weak, and they can contribute significantly to the 
overall binding affinity, particularly where complex chemical surfaces are involved. For 
example, the non-specific adhesion of cells even to a relatively homogeneous surface 
such as a self-assembled monolayer can vary significantly with the details of the surface 
and the cells and its magnitude can dominate any specific interactions[4].  In fact in many 
cases the nonspecific interactions make up the bulk of the binding affinity with the 
specific interactions serving largely to limit the orientational entropy of the system.  In 
such cases, the concepts of specific and nonspecific binding are probably better thought 
of as two ends of a more continuous spectrum.  For example, in the interaction between 
an endonuclease and DNA is initially a charge-charge interaction and indeed this is a 
large fraction of the binding force[5].  This interaction allows the endonuclease to stay in 
the correct general orientation relative to the DNA but to diffuse along it without forming 
a specific structure until the site of action is reached [5-7].  The initial interaction is, in 
fact, quite specific for DNA.  It is just not associated with a particular DNA structure 
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(sequence).  Likewise, the general characteristics of a surface can result in very large 
discrimination between binding partners, even though no specific structures are formed.  
A number of different methods have been used to characterize and to alter the 
interaction of biological macromolecules with surfaces.  Metal or nanoparticle patterning 
has been used to create surfaces that differentially bind components of complex 
mixtures[8]. For example, Gilles et al. developed an approach to control cell adhesion 
and guide neurite outgrowth by patterned deposition of gold nanoparticles[9].  Yu et al. 
chemically modified hydrogels with nitrilotriacetic acid to enable protein immobilization 
at selected sites[10]. DNA and peptide microarrays are useful for exploring the diversity 
of interaction with proteins and other macromolecules because they present a set of 
sequences with great chemical complexity that can be precisely controlled. Surface-
bound peptides, in particular, have considerable potential because of the broad chemical 
diversity that can be represented in relatively modest length sequences[8].  Another 
application that utilizes a library of relatively short peptides for discrimination of 
complex mixtures is immunosignaturing[11].  In that case, surface bound peptides are 
exposed to blood, binding to circulating antibodies and providing a profile of the 
antibody repertoire.  This antibody profile is strongly correlated with disease state or 
immunological response to a vaccine [11, 12].  
Here, the nature of nonspecific binding between proteins and surfaces covered 
with particular peptide sequences will be explored.  This will be accomplished by 
systematically studying the binding of a number of different proteins to modest sized 
libraries of short (2-12 amino acid residue) peptides in ordered arrays on surfaces. 
Specifically, the affinity of specific proteins and the relative binding of different proteins 
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(the degree of differential binding) will be monitored as a function of the hydrophobicity, 
charge and length of peptides in the ordered arrays.  While the general role of charge and 
hydrophobicity are relatively intuitive, it is less obvious how changing the length of the 
peptide bound to the surface will affect binding.  First, increased length corresponds to 
increased chemical complexity; the more residues in each peptide, the greater the number 
of possible peptides that can be made.  In the work described below, the choice of 
sequences is purely random and the libraries are too small to expect to create highly 
specific contacts.  Second, longer peptides of random sequence tend to be more nonpolar 
on average.  Third, as length is increased, the total number of possible interactions 
between a specific peptide and a protein increases; in principle, a greater number of 
interaction points between the peptide and protein should result in greater affinity, though 
there are both steric issues and entropy penalties involved.  Finally, the possible number 
of peptide structures increases as the length is increased; this could result in partially 
specific structural pairing between peptide and protein, though again, conformational 
entropy comes into play. 
MATERIALS AND METHODS 
Peptide Microarrays 
The peptide microarrays used were ordered as custom arrays from LC Sciences 
(Houston, TX)[13]. This company fabricates peptide arrays comprised of 30,000 
peptides, up to 12 amino acids in length (below referred to as the ‘variable’ region). The 
array was divided in 6 identical sub-arrays (5000 features on each sub-array) and each 
was bound under same conditions, but with different protein samples. A sub-set of 7 of 
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the 20 natural amino acids {E, L, S, R, Q, W, Y} was used for peptide synthesis.  Using 
such a sub-set of amino acids allows the study of a larger percentage or full sequence 
space for short peptides. These particular residues were chosen because they span the 
hydropathic index[14, 15] and produce a net neutral charge between them, while reducing 
the complexity of the peptide array synthesis by not using the entire set of 20 amino 
acids.  
Each sub-array contains 4876 custom peptides (the rest are control peptides 
provided by the company).  The peptide length was varied from 2 to 12 residues.  All 
possible dipeptides (49), tripeptides (343) and an equal distribution of randomly selected 
tetrapeptides (896), pentapeptides (897), heptapeptides (897), nonapeptides (897) and 
dodecapeptides (896) were included in the library. A GSG tri-peptide linker was added to 
the C terminus of each sequence to maintain a uniform distance between the peptides and 
the array surfaces in addition to the proprietary surface linker[16] used by LC Sciences. 
 
Protein Binding 
 Alexa Fluor®-555 (AF555, Invitrogen) and Alexa Fluor®-647 (AF647, 
Invitrogen) labeled proteins were used for the protein-peptide binding assay. The labeling 
was done using a kit (Invitrogen) and the manufacture’s protocol was followed in the 
protein labeling process. β-galactosidase, α1-antitrypsin and a protein mixture included 
Fetuin, Horseradish peroxidase, Bovine serum albumin, Carbonic anhydrase 
Haptoglobin, Transferrin, Amylase, Pyruvate Kinase and Glucose Oxidase were used in 
the binding assays. Table 2.1 lists the size, pI, accessible solvent surface area, source, 
company and the estimated surface area relative to β-galactosidase for each protein. The 
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concentration of protein used in each case was adjusted to give a constant total surface 
area calculated according to footnote [e] of Table 2.1. Dye/ α1-antitrypsin labeling ratios 
were kept near 1 due to the small size of this protein and the increased possibility of 
dominant dye interactions. β-galactosidase, being a much larger protein is somewhat less 
sensitive to covalent addition of labeled dyes and thus for this protein labeling ratios were 
allowed to go as high as 3. The proteins in the mixture were labeled separately and then 
mixed together. The labeling ratios for each protein in the mixture were kept below 1. 
The final dye/protein ratio in the mixture was 0.5 (unlabeled proteins were added to the 
corresponding labeled proteins whose ratios were over 0.5 before the mixing to control 
the overall fluorescence intensity).  
Table 2.1: Summary of proteins used in the binding assays 
Protein Size 
(KDa) 
pI[a] Accessibl
e surface 
(Å2)[c] 
Accessible 
hydrophobi
c  
(Å2) [d] 
Sourc
e 
Compan
y  
Rel. 
surfac
e 
area[e]  
β-
galactosidase[
17, 18] 
464 4.61 3.00×105 3.49×104 Esche
richia 
coli 
Sigma 
G6008 
1.000 
α1-
antitrypsin[19] 
50-56 5.37[b] 2.34×104 3.20×103 Huma
n 
plasm
a 
Sigma 
A9024 
0.226 
Fetuin (Type 
III)[20] 
48.4 3.3 N/A[c] N/A[c] Fetal 
calf 
serum 
Sigma  
F2379 
0.222 
Horseradish 
peroxidase 
(Type VI)[21, 
22] 
44 7.20 2.76×104 3.07×103 Horse
radish 
Sigma 
P8375 
0.208 
Bovine serum 
albumin[23, 
24] 
66.4 5.3 6.70×104 1.25×104 Bovin
e 
serum 
Sigma 
A7906 
0.274 
Carbonic 
anhydrase(Iso
31 5.9 4.66×104 3.98×103 Bovin
e 
Sigma 
C2522 
0.165 
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zyme II)[25] erythr
ocytes 
Haptoglobin 
(Mixture type) 
~86 6.13[b] 8.60×104 1.31×104 Huma
n 
plasm
a 
EMD4B
ioscienc
es 
372022 
0.325 
Transferrin[26
] 
77 6.90 3.20×104 5.78×103 Huma
n 
blood 
Sigma 
T3309 
0.302 
α-Amylase 
(Type II-
A)[27] 
50 7.00 2.00×104 2.54×103 Bacill
us sp. 
Sigma 
A6380 
0.226 
Pyruvate 
Kinase (Type 
III) 
237  7.60 7.25×104 1.69×104 Rabbi
t 
Muscl
e 
Sigma 
P9136 
0.639 
Glucose 
Oxidase[28, 
29] 
160 
 
4.20 8.10×104 1.07×104 Asper
gillus 
niger 
Sigma 
G7141 
0.492 
[a] pI is the abbreviation for the isoelectric point, which is the pH at which the particular 
protein carries no net electrical charge 
[b] These values were theoretical values calculated based on the peptide sequences 
[c]These values were calculated in PyMol using the corresponding protein crystal 
structure information from PDB database 
[d] Crystal structure information for bovine fetuin is not available in major databases 
[e] The relative surface area was calculated assuming that each protein could be 
considered as a perfect sphere using the equation [(molecular weight of sample 
protein)/(molecular weight of β-galactosidase)]2/3  
 
In order to test directly for effects of the dye on binding, proteins were labeled 
with two different dyes and all experiments were done with both protein samples. AF555 
and AF647 labeled proteins were applied on identical sub-arrays respectively under the 
same experimental conditions. Peptides exhibiting significantly different binding 
behaviors between the two dyes were excluded from further data analysis, except as 
indicated.  
 The actual protein binding assays were performed by LC Sciences (LC Sciences 
both synthesized the arrays and performed the binding experiments). The following 
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procedures and conditions for binding were used.  First, the chips were treated with 
blocking buffer (super block, a proprietary blocking solution, with 0.05% Tween-20 and 
0.05% Triton X-100, pH7.4) overnight to minimize non-specific binding and then washed 
in washing buffer (1×PBS, pH 7.0). Second, the six different protein samples (AF555-β-
galactosidase, AF647-β-galactosidase, AF555-α1-antitrypsin, AF647-α1-antitrypsin, 
AF555-protein mixture and AF647-protein mixture) were applied to 6 sub-arrays 
respectively and incubated for 1 hour in binding buffer (1×PBS, pH7.4) at 25°C. Third, 
the array was washed with washing buffer and imaged using either 635 nm excitation and 
655-695 nm emission filter or 532 nm excitation and 550-600 nm emission filter, 
depending on which dye was used.  Note that blank features on the array, left as a control, 
showed binding levels that were essentially the same as the lowest levels of protein 
binding. 
 Additionally, to verify that the relationships between binding and peptide 
sequence on the LC science arrays were not simply unique to that platform, 14 peptides 
that had been tested on the array were resynthesized by Sigma-Aldrich PepScreen® 
service and bound to the surface of microwell plates.  These peptides covered the full 
range of binding strengths to β-galactosidase.  Binding with AF555 and AF647 labeled β-
galactosidase was repeated and the binding results compared (in terms of the binding 
rank) between the two platforms (Table S2.1).  The order was very similar, implying that 
both the sequences from the two sources were, indeed, the same and the exact nature of 
the surface and attachment is not critical. 
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Data Analysis 
Binding signals were normalized to the median intensity for each respective sub-
array[30]. All subsequent analysis utilized the median-normalized data. For β-
galactosidase and α1-antitrypsin, data from arrays bound with same protein but using 
different dye labels was compared, and peptides with binding values that were more than 
2-fold different between the samples were excluded in further analyses (see Results). 
There were 4876 total peptides in the array, for β-galactosidase 897 were excluded and 
for α1-antitrypsin 1490 were excluded. For the protein mixture, binding signals from 
arrays bound with same mixture but using different dye labels were averaged and the 
mean of the binding signals was used in further analyses. Locally written scripts in either 
Matlab or Bash Shell environment were used to sort the peptides with different lengths 
and to perform most of the statistical studies. An online bioinformatics tool was used to 
generate the Venn Diagram[31].   
RESULTS 
 Two proteins, β-galactosidase and α-1 antitrypsin were incubated with the LC-
sciences peptide arrays, as described in Methods.  The binding of these particular proteins 
was then compared to that of a mixture of 9 other proteins of various sizes and pI values 
(Table 1).  These proteins were chosen to cover a broad range of sizes and isoelectric 
points.  For both β-galactosidase and α-1 antitrypsin, the binding intensities for proteins 
labeled with two different fluorescent dyes (AF555 and AF647, see Methods) were 
compared and peptides that were suspected of binding dye primarily, rather than the 
protein, were removed from further analysis.  The peptide arrays used for this analysis 
consisted of peptides ranging from 2 to 12 amino acids in length of random sequence (the 
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sequence of each peptide feature is homogeneous but selected with a random number 
generator) (see Methods for more details).  This array composition makes it possible to 
explore various dimensions of protein interactions with complex surfaces.  Even with 
very modest sized peptide libraries such as this, the dynamic range of the protein 
association with the surface is very high.  For example, using β-galactosidase, the highest 
signals are roughly 60-fold higher than the lowest signals (Table 2.2).  With small 
libraries, it is unlikely that the binding is strongly dependent on rigid structural 
interactions.  Instead, long range interactions (charge) and small numbers of specific 
contacts enabled by the flexibility of the peptide chains are more likely.  In order to 
explore this in more detail, the peptide set and associated binding was parsed in a number 
of ways: total charge, hydrophobicity and length. 
Table 2.2: Peptides-protein binding dynamic range for each protein sample 
Sample 
Average Binding of 
the top 10 peptides 
Average Binding of 
the bottom 10 
peptides 
Fold change[a] 
β-galactosidase 18.54 0.29 63.9 
α1-antitrypsin 2.97 0.50 5.92 
Mixture with 9 
proteins 
4.78 0.45 10.6 
[a] These values represent the fold change between binding of strongest binding peptides 
and weakest binding peptides. The equation used for calculating these values is: (Average 
binding of the top 10 peptides) / (Average binding of the bottom 10 peptides) 
 
Effect of charge and hydrophobicity on surface affinity  
The charge of both a protein and the surface it interacts with will play a major role 
in differential protein binding.  β-galactosidase has a pI of 4.61 and α1-antitrypsin  has a 
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pI of 5.37 (Table 2.1), thus both are negatively charged at neutral pH.  In fact most of the 
proteins used in the protein mixture are negatively charged under the binding conditions 
used here.  This is reflected in Figure 2.1 which shows how each of the protein samples 
tested interacts with peptides on the surface as a function of net peptide charge at neutral 
pH.  All of the protein samples show higher affinity to surface features consisting of 
peptides that have more positive charges.  The affect is particularly pronounced for β-
galactosidase where the average binding intensity for positively charged peptides is 6.8 
fold higher than that of negatively charged peptides and 2.9 fold higher than neutral 
peptides.  α1-antitrypsin and the mixture of nine proteins show a considerably less 
pronounced increase (1.5 fold for α1-antitrypsin and 2.5 fold for the protein mixture 
relative to negatively charged peptides, Figure 2.1).  
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Figure 2.1. Average binding intensity as a function of net charge per peptide .  The 
net charge of the peptides at neutral pH varies from -5 to +6. Intensity values shown are 
normalized to the median for each sample.  The error bars shown represent the standard 
error in the mean for peptides with that net charge. 
Charge is not the only physical parameter of the peptides that can strongly 
correlate with binding.  As seen in Figure 2.2, the overall hydrophobicity of the peptide 
on each feature in the array also substantially affects the affinity of proteins for that 
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feature.  In this case, however, the effects are different for the three protein samples. The 
hydrophobicity of each peptide was estimated from the sum of the hydrophobicity values 
for each amino acid [32].  Based on this, the peptides were sorted into four groups (very 
hydrophobic, hydrophobic, neutral and hydrophilic) according to their hydrophobicity 
value.  At the highest hydrophobicity, β-galactosidase binding dropped by 2/3rds of its 
binding value for more polar peptides (Figure 2.2).   In contrast, α1-antitrypsin binding 
increases by nearly 1/3rd as hydrophobicity increases. The mixture of nine proteins gives 
intermediate results, with a small increase in average binding for peptides with higher 
hydrophobicity values (about 15%).  
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Figure 2.2. Binding intensity as a function of peptide hydrophobicity. The binding 
intensities from peptides of each hydrophobicity group were averaged together.  There 
were four hydrophobicity groups. Group 1 ( hydrophilic): hydrophobicity < -10; group 2 
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(neutral): hydrophobicity 20 to -10; group 3 (hydrophobic): hydrophobicity 20 to 70; 
group 4 (very hydrophobic ) hydrophobicity > 70. Intensity values shown are normalized 
to the global median.  The error bars shown represent the standard error in the mean for 
that peptide hydrophobicity group. 
Effect of peptide length on surface affinity  
Features in the array with longer peptides have potentially more complex 
chemical properties, by virtue of the fact that more chemically different amino acids are 
present and the number of possible sequences becomes exponentially larger with peptide 
length.  One might think that binding would simple become stronger with length due to 
the larger number of possible interactions, however, previous work from the authors’ 
laboratory suggested that the dependence of binding on peptide length was more complex 
than this[14], at least in some cases, prompting a more detailed study.  The average 
binding intensity as a function of length for the three protein samples is shown in 
Figure2.3.  For β-galactosidase, there appear to be two observable maxima, though the 
statistical validity is borderline.  In any case, there is a ~2-fold increase in average 
binding observed as the peptide length is increased from 2 to 4 amino acids, but then the 
average binding signal seems to peak ~4 amino acids.   As the length is increased beyond 
~7 amino acids, the binding drops so that by 12 amino acids the average binding is 
similar to the binding to amino acid dipeptides.  The situation for α1-antitrypsin is 
different.  In contrast to β-galactosidase, the average binding affinity of α1-antitrypsin to 
the peptide array increases monotonically, or nearly so, with peptide length. The protein 
mixture shows essentially no significant length dependence of binding besides a small 
apparent decrease in binding signal at a peptide length of 7 amino acids. 
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Figure 2.3. Average binding affinity versus length for each protein sample. The 
binding intensities from peptides of each length were averaged together.  All values are 
normalized to the average binding intensity of the corresponding dimer peptide for that 
sample.  The error bars shown represent the standard error of the mean for that peptide 
length. 
More can be learned from looking at the distributions of peptide binding as a 
function of length.  This is shown in Figure 2.4 for β-galactosidase.  The binding 
distributions reflect the population of peptides that are bound to the labeled proteins at 
each length (each length is normalized so that the intensities shown for each length of 
peptide are given as a fraction of the total fluorescence).  As might be expected, most 
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peptides of all lengths show relatively weak binding to β-galactosidase, and the number 
of peptides that bind at successively higher intensities falls off rapidly.  There are a small 
number of peptides however that bind with quite high intensity.  Similar distributions are 
seen for both α1-antitrypsin and the protein mixture (see supplementary material).   
 
Figure 2.4: Histogram of β-galactosidase binding distribution as a function of 
peptide length. Fluorescence intensities shown are normalized to the total fluorescence 
intensity for the peptides of a particular length. 
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This brings up the question of whether the high binding signals have the same 
length dependence as does the average binding shown in Figure 2.3.  One might think 
that the best binders would always be the longest ones, as these would simply have more 
to offer in terms of possible interactions.  When the average signal from only the top 30 
binding peptides at each length is plotted, the length dependence is generally similar to 
that seen for the average of all peptides in Figure 2.3 (Figure S2.3).  However, when just 
the top binders are considered, binding for β-galactosidase does not drop as dramatically 
for longer peptides as it does when all peptide features are averaged.  In addition, the 
peak of the binding shifts to longer peptide lengths, from of 7 to 9 amino acids.  Finally, 
in the case of the protein mixture, the best binders are clearly the longer peptides, 
whereas the average of all peptides showed little length dependence.  Thus, in general, it 
appears that the best binders are biased towards the longer peptides. 
The relationship between length, charge and hydrophobicity 
Peptide length is not entirely independent of charge and hydrophobicity; for 
randomly chosen sequences, longer peptides tend to be more hydrophobic and are 
statistically more likely to have more balanced charge characteristics.  The relationship 
between binding, charge and length is shown for β-galactosidase in Figure 2.5.  Here the 
length dependence of binding is plotted for positive, negative and neutral peptides.  
Negative peptides show less dependence on length (though still bind statistically better 
for mid-length than long peptides) while positive, and to a lesser extent neutral, peptides 
show a strong length dependence.  This is particularly evident with regard to the drop in 
binding for longer, positive peptides; in this case, the binding to 12-mers is 2-fold lower 
than that to peptides that are 2-4 amino acids long.  Very similar studies were performed 
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on α1-antitrypsin and the protein mixture (see supplementary material). In those two 
cases, charge had little effect on the length dependence. 
 
Figure 2.5.  β-galactosidase average binding intensity versus peptide length for each 
charge group. The binding intensities from peptides of a particular net charge and length 
were averaged together.  In this study, there were 1387 positively charged peptides (black 
squares), 1286 neutral peptides (red circles) and 1305 negatively charged peptides (green 
triangles). The intensity values shown are normalized to the median for each charge 
group. The error bars shown represent the standard error of the mean for that peptide 
length and net charge. 
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One might think that the observed drop in β-galactosidase binding at longer 
lengths may arise from the tendency of longer peptides to be more nonpolar, given the 
fact that more hydrophobic peptides tend to bind β-galactosidase more weakly (Figure 
2.2).  However, when the peptides were separated into hydrophilic, neutral, hydrophobic 
and very hydrophobic, all four classes showed lower binding at long lengths (Figure 
S2.6).  The only significant difference was the behavior at shorter lengths, where the 
hydrophilic short peptides bound more strongly than the others.  
The average binding intensity for α1-antitrypsin and protein mixture versus 
peptide length for four hydrophobicity groups was also studied but no significant 
difference in the overall binding trends was observed. (Figures not shown). 
Discrimination between proteins 
To what extent does a modest library of different peptides provide differential 
binding of one protein vs. another?  Figure 2.6 shows a Venn diagram of the top 100 
peptides binding to the three samples tested.  There is generally very little overlap in 
which peptides bind best to each sample.  By random chance, one would have expected 
approximately 2 peptides to be common between each sample.  What one sees is that α1-
antitrypsin shows about this expected overlap with the protein mixture, but both α1-
antitrypsin and the protein mixture show a somewhat greater than random overlap with β-
galactosidase.  This is presumably because of the general propensity for positively 
charged peptides, particularly in the case of β-galactosidase, limiting the set of peptides 
from which the top 100 were selected.  Still, even among highly positive peptides, there 
is an ability to distinguish easily between bindings to the three different protein samples. 
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Figure 2.6. Venn diagram[31] of the highest affinity 100 peptides that bind to β-
galactosidase, α1-antitrypsin and the mix of 9 proteins. There were 4876 total peptides 
in the array, but, 377 were excluded due to obvious dye effects on binding to both β-
galactosidase and α1-antitrypsin.  
Another way to consider the level of specificity of binding is to compare the way 
binding depends on charge, hydrophobicity and length in the two specific proteins β-
galactosidase and α1-antitrypsin) relative to the mixture of 9 proteins.  One can see from 
Figure 2.3, that the mixture shows little length dependence on average binding, 
suggesting that the forces that result in changes in affinity as a function of length also 
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discriminate different proteins from each other.  More enlightening are the curves 
depicting the ratio between binding of each of the two individual proteins (β-
galactosidase and α1-antitrypsin) and the mixture as a function of charge and 
hydrophobicity.  As a function of charge (Figure 2.7), the specificity ratio for β-
galactosidase increases in essentially the same way as does the affinity in Fig. 2.1; larger 
positive charge results in more binding of β-galactosidase compared to a mixture of nine 
proteins.  However, for α1-antitrypsin, while binding overall increases somewhat for 
positively charged peptides, it does so less than the aggregate of the other nine proteins.  
Thus positively charged peptides in general are less selective for α1-antitrypsin than are 
negatively charged peptides. 
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Figure 2.7.  Relative binding discrimination as a function of net charge per peptide. 
The relative average binding discrimination (the ratio of average binding of β-
galactosidase or α1-antitrypsin  the average binding of the mixture of 9 proteins) is 
shown for peptides of each net charge group. The values are normalized to the global 
median before the ratio calculation. The error bars shown represent standard errors of the 
mean for each value. 
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Perhaps not surprisingly, given the charge effects described above and the 
hydrophobicity results of Figure 2, β-galactosidase binds most selectively to hydrophillic 
peptides while α1-antitrypsin binds most selectively to hydrophobic peptides (Figure S7).   
DISCUSSION 
The interaction of proteins with surfaces, and particularly with chemically 
complex surfaces such as the ones described here, is of considerable interest both in 
terms of what it potentially tells us about protein-surface interactions in cells and in terms 
of its potential for utility in developing surfaces with selective binding or nonbinding 
properties for practical use.  In this context, there are several important observations 
about the dependence of protein/surface interactions on the properties of peptides 
tethered to a surface.   
One observation is that even short peptides can have both strong and diverse 
interactions with proteins.  Some of the strongest binding peptides are comprised of just a 
few amino acids (Table 2.2, Figure 2.3) and dynamic range among short peptides was 
almost as great as among long ones.  The binding of short peptides is strongly dictated by 
charge, as evidenced by the fact that highly positively charged 2-4 amino acid peptides 
show some of the strongest binding, particularly for β-galactosidase (Figure 2.5).   
More importantly, the peptides that interact with one protein are distinct from 
those that interact with others. The Venn diagram of Figure 6 shows that the overlap 
between the peptide features that bind the best to the three samples is minimal. The 
somewhat larger degree of overlap between β-galactosidase and the protein mixture 
arises because β-galactosidase is a large tetrameric protein with low pI (around 4.7) and 
therefore binds strongly to most positively charged peptides (all of the peptides that are in 
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common between β-galactosidase and the protein mixture are positive charged with two 
or more Arginine residues). Not only are the peptides that bind well different for different 
proteins, but their dependence on peptide charge, hydrophobicity and length is also 
unique. β-galactosidase is selectively favored by highly charged peptides between 4 and 9 
amino acids in length when compared to the binding of a mixture of 9 proteins and 
disfavored by long, hydrophobic peptides; α1-antitrypsin behaves almost in the opposite 
fashion, preferring the longer, more hydrophobic peptides. 
Interestingly, the isolectric point and the fraction of the surface area consisting of 
solvent accessible hydrophobic amino acid side chains (Table 2.1) are not that different 
between β-galactosidase and α1-antitrypsin.  Both are strongly negative proteins at the 
pH tested and both have between 11 and 14% of the surface area composed of 
hydrophobic amino acids.  Yet, in terms of their interactions with the surface, they 
behave very differently.  This may have to do simply with the size difference; because of 
its larger size, there is more opportunity for weak, long-range interactions, like columbic 
interactions, to have an effect, whereas for a smaller protein, the shorter range 
interactions between hydrophobic regions excluding water may be more important. 
With the growing commercial availability of both peptide arrays and the ability to 
create libraries of peptides on a wide variety of surfaces, it has become practical and cost 
effective to empirically tune the chemical properties of a surface by selecting appropriate 
molecules from surface-based molecular libraries of peptides or related heteropolymers.  
The number of companies that will generate peptide libraries on surfaces either via 
synthesis and printing or in situ synthesis is growing.   While selection of peptides from 
small libraries is unlikely to provide antibody-level affinity and specificity, even very 
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simple sequences can provide quite selective chemical properties and interactions among 
multiple components, opening the possibility for using this approach to very simply and 
quickly create surfaces with specific properties relative to their interactions with complex 
mixtures such as blood as well as spatially patterned interactions.  These experiments 
were designed to be interpreted at a high level, without granular dissection of amino acid 
sequences, but rather at the level of general peptide characteristics.  Protein:peptide 
interactions can be mapped and described with a small number of peptides because the 
design of those peptides can be optimized to take advantage of this interaction level, 
rather than attempting to create peptides requiring a highly granular level of detail and 
sequence-specific analyses.  Additionally, because these are entirely synthetic systems, a 
wide variety of non-natural chemical variations can be easily incorporated, providing 
surfaces with both a wider diversity of chemical characteristics as well as resistance to 
biological degradation, adding flexibility to a measurement system that is well-suited for 
generalizing binding interactions. 
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SUPPORTING INFORMATION 
Distribution of peptide binding as a function of length 
The peptide binding distribution as a function of length for α1-antitrpsin and the 
protein mixture are shown in figures S2.1 and figure S2.2. The distributions reflect the 
relative population of peptides that are bound to the labeled proteins at each length. As 
was the case for β-galactosidase, most peptides of all lengths show relatively weak 
binding but there are a small number that bind with high intensity.  
 
Figure S2.1 Three dimensional histogram of α1-antitrpsin binding distribution as a 
function of peptide length.   Details as in Figure 4. 
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Figure S2.2 Three dimensional histogram of protein mixture binding distribution as 
a function of peptide length.  Details as in Figure 2.4. 
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Length dependence for peptide with high binding signals 
Figure S2.3 shows the average signal from only the top 30 binding peptides at 
each length, the length dependence is generally similar to that seen for the average of all 
peptides in Figure 2.3.   
 
Figure S2.3. The average fluorescence intensity from the 30 peptides with the 
greatest affinity for a particular sample as a function of peptide length.  The values 
shown are averages of the median-normalized binding intensity of peptides of a particular 
length.  The error bars shown are calculated as standard error of the mean. 
The relationship between length and charge 
The relationship between peptide length and charge was studied by plotting the 
average binding intensity versus peptide length for each charge group. Figure S2.4 and 
Figure S2.5 show the length dependence of binding for positive, negative and neutral 
peptides for α1-antitrypsin and the protein mixture, respectively. The binding curves for 
both α1-antitrypsin and the protein mixture do not depend strongly on charge.  
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Figure S2.4 α1-antitrypsin average binding intensity versus peptide length for each 
charge group. Details are as in Figure 5 except that there were 1183 positively charged 
peptides (black squares), 1231 neutral peptides (red circles) and 971 negatively charged 
peptides (green triangles).  The error bars shown represent the standard error in the mean 
for that peptide length. 
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Figure S2.5 Protein mixture average binding intensity versus peptide length for each 
charge group. Details as in Figure 5, except that there were 1646 positively charged 
peptides (blue squares), 1539 neutral peptides (cyan circles) and 1690 negatively charged 
peptides (magenta triangles).   The error bars shown represent the standard error in the 
mean for that peptide length. 
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The relationship between length and hydrophobicity 
The average binding intensity for β-galactosidase versus peptide length for four 
hydrophobicity groups is shown in Figure S2.6.  All four groups show lower binding 
intensities at long lengths.  
 
Figure S2.6 β-galactosidase average binding intensity versus peptide length for each 
hydrophobicity group. The binding intensities from peptides of each length were 
averaged together.  There were 3014 peptides in the very hydrophobic group, 476 
peptides in the hydrophobic group, 192 peptides in the neutral group and 296 peptides in 
the hydrophilic group.  Intensity values shown are normalized to the global median for β-
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galactosidase. The error bars shown represent the standard error in the mean for that 
peptide length. 
Relative binding discrimination as a function of peptide hydrophobicity 
Figure S2.7 shows the ratio between the binding of each of the two individual 
proteins (β-galactosidase and α1-antitrypsin) and the mixture as a function of 
hydrophobicity. The results suggest that β-galactosidase binds most selectively to 
hydrophillic peptides while α1-antitrypsin binds most selectively to hydrophobic 
peptides. 
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Figure S2.7. Relative binding discrimination as a function of peptide 
hydrophobicity. The relative average binding discrimination (see Fig. 2.7) between 
peptides of each hydrophobicity group (defined in Fig. 2.2) are shown for β-galactosidase 
and α1-antitrypsin. The error bars represent standard errors of the mean for each value. 
 
Comparing β-galactosidase binding on two different peptide-conjugated surfaces
 Prior to the protein binding experiment on the 30K LC Sciences array, similar 
binding experiments were performed on the same type array to both confirm that the 
sequences on the LC Science arrays were as advertised and that the nature of the binding 
surface itself does not dominate the results. To accomplish this, 14 peptides were selected 
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from an LC Sciences array, synthesized and purified.  These were bound to microwell 
plates, protein was incubated with each peptide and the level of protein bound was 
measured on a SpectraMax M5 96 well plate reader (Molecular Device, Sunnyvale, CA) 
using a slightly modified version of a procedure previously published[33]. First, 30 µL of 
SMCC solution (10mM in 1× PBS buffer, pH 7.4)  was added into each aminated 
microwell and incubated for one hour at room temperature to activate the surface. The 
microwell plate was briefly washed with pure water three times to get rid of extra SMCC. 
Second, 30 µL peptide solution (300 µM in 1× PBS buffer, 1 mM TCEP, pH 7.4) was 
added to the appropriate SMCC-activated microwells. The reaction was incubated for 4 
hours at room temperature, in the dark to allow the peptide to conjugate to the surface. 
After the conjugation reaction was complete, the microwells were washed for 5 minutes 
in 1× TBST, three times, followed by three washes in water to remove free peptides. 
Third, 30 µL of biotin-labeled β-galactosidase (10nM in 10 mM phosphate buffer with 
0.05% Tween 20 (v/v%), pH 7.4) was then added to corresponding wells and incubated 
for two hours at room temperature. The microwells were then washed for 5 minutes in 1× 
TBST, three times, followed by three washes in phosphate. Finally, β-galactosidase 
binding level was measured using an enzyme linked immunosorbant assay (ELISA).  30 
µL of Alkaline phosphatase-conjugated strepavidin solution (0.4 mg/ml diluted at 1 1000 
in 1× PBS, 0.05% (v/v) Tween 20) was added to the biotin-β-galactosidase-bound wells 
and incubated for one hour at room temperature. The streptavidin solution was then 
removed and the plate was washed three times with TBST buffer and three times with 
TBS buffer. Then, 200 µL of 1 mM PNPP was added to each well. The alkaline 
phosphatase activity was subsequently measured by reading the absorbance increase at 
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405 nm on the M5 plate reader. The β-galactosidase binding level was determined from 
the activity of alkaline phosphatase-conjugated strepavidin bound to the wells. 
Table S2.1 shows the rank of protein binding level to each selected peptide 
sequence. Although the rank order varies somewhat, the stronger binders stay strong and 
the weaker binders stay weak on both binding platforms. This confirms that the measured 
binding signals reflect the binding levels between β-galactosidase and the surface-bound 
peptides, rather than the surface itself.  
Table S2.1: The rank of β-galactosidase binding level to each selected peptide 
sequence 
Sequence 
Rank in LC Science 
platform 
Rank in microwell platform 
RYYSSRLRYGSG 1 1 
SRYYGSG 2 4 
YRSRYRQQQGSG 3 5 
QRYYGSG 4 3 
YRYYSGSG 5 2 
WRYYQRSQYGSG 6 7 
QRYQRSRSYGSG 7 8 
RQYSGSG 8 6 
YQWRRGSG 9 9 
RLERSRQERGSG 10 11 
RRQEGSG 11 10 
EQRYREEREGSG 12 12 
QLSEESELLGSG 13 14 
RWESGSG 14 13 
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CHAPTER 3: UNSTRUCTURED INTERACTIONS BETWEEN PEPTIDES AND 
PROTEINS: EXPLORING THE ROLE OF SEQUENCE MOTIFS IN AFFINITY 
AND SPECIFICITY 
ABSTRACT 
Unstructured interactions between proteins and other molecules or surfaces are 
often described as nonspecific, and have received relatively little attention in terms of 
their role in biology. However, despite their lack of a specific binding structure, these 
unstructured interactions can in fact be very selective. The lack of a specific structure for 
these interactions makes them more difficult to study in a chemically meaningful way, 
but one approach is statistical, simply looking at a large number of different ligands and 
using that to understand the chemistry of binding. Surface-bound peptide arrays are 
useful in this regard, and have been used as a model previously for this purpose (Wang et 
al., Acta Biomater. 2014;10:761-8).  In that study, the binding of several proteins, 
including β-galactosidase, to all possible di-peptides, tri-peptides and tetra-peptides 
(using 7 selected amino acids) was performed and analyzed in terms of the charge 
characteristics, hydrophobicity, etc. of the binding interaction. The current work builds 
upon that study by starting with a representative subset of the tetrapeptides characterized 
previously and either extending them by adding all possible combinations of one, two and 
three amino acids, or by concatenating 57 of the previously characterized tetrapeptides to 
each other in all possible combinations (including order).  The extended and concatenated 
libraries were analyzed by binding either labeled β-galactosidase to them or by binding a 
mixture of ten different labeled proteins of various sizes, hydrophobicities and charge 
characteristics to the peptide arrays.  By comparing the binding signals from the 
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tetrapeptides or amino acid extensions alone to the binding signals from the complete 
extended or concatenated sequences, it was possible to evaluate the extent to which 
affinity and specificity of the whole sequence depends on the subsequences that make it 
up.  The conclusion is that while joining two component sequences together can either 
greatly increase or decrease overall binding and specificity (relative to the component 
sequences alone), the contribution to the binding affinity and specificity of the individual 
binding components is strongly dependent on their position in the peptide; component 
sequences that bind strongly at the C-terminus of the peptide do not necessarily add 
substantially to binding and specificity when placed at the N-terminus. This work has 
been submitted to Acta Biomaterialia and is under review.  
INTRODUCTION 
When one thinks about the kinds of interactions proteins have in biological 
systems, generally what comes to mind are specific interactions: antibody-antigen 
binding, receptor-ligand binding, enzyme substrate binding, etc. However, given the 
extraordinarily crowded environment of the cell, the vast majority of the encounters that 
proteins have with each other or with the boundaries of the compartments that surround 
them are nonspecific.  Here nonspecific interactions might also be referred to as 
unstructured interactions, interactions that do not involve the formation of a stable 
complex that has a homogeneous structure. Most biological processes comprise large, 
intricate interaction networks which include both specific and nonspecific interactions[1, 
2] and some of these processes cannot function properly without the participation of 
nonspecific interactions. For example, nonspecific (unstructured) interactions between 
proteins (or enzymes) and the nucleic acids are important determinants of biological 
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function[3] . The initial, unstructured interactions of proteins with DNA or RNA can help 
to facilitate binding to specific sites by reducing the dimensionality of diffusion in DNA 
replication and DNA modification, by forming distorted binding geometries to activate 
transcription processes, or even by more indirect regulation of gene expression [4][5][6].  
While most of these interactions do not involve the initial formation of specific 
structures, they can in fact be both quite strong and quite selective in terms of biological 
function.  
Other examples of biological processes that emphasize the nature of unstructured 
interactions include proteins selectively NOT adsorbing to other macromolecules in 
crowded cellular environments[7-9] and Phosphatidylinositol transfer proteins (PITPs) 
localizing to the trans-Golgi network by both specific and nonspecific membrane-binding 
components[10].  Even the transfer of substrates between enzymes can utilize 
unstructured interactions to keep the local concentration of product/substrate high and 
facilitate transfer [11]. Indeed, protein interactions in biology almost certainly represent a 
continuum between structurally defined interactions with long residence times and 
transient unstructured interactions.  
Of particular significance, both to our understanding of fundamental biology and 
to practical application, are nonspecific or unstructured interactions between proteins and 
complex surfaces.  Though ubiquitous, these interactions are difficult to characterize for 
the very reason that they lack specific structures.  Further, the interactions, often involve 
a protein and multiple molecules or parts of molecules on a surface.  This can be quite 
different from a situation where one protein is interacting with one ligand; it is more one 
surface interacting with another. Though poorly defined structurally, these types of 
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interactions are clearly selective. Nature uses selective, unstructured interactions between 
protein surfaces and complex surfaces in their surroundings to its advantage and 
mimicking that kind of selectivity is a key aspect of developing biomaterials or 
biosensors with surfaces that avoid background binding and interference, but facilitate 
selected interactions[7, 8].  
Biological surfaces are very complex and clearly have been tuned to encourage 
certain types of interactions, both structured and unstructured, in particular places.  Thus 
far, the design and fabrication of artificial surfaces that interact with proteins has not 
taken full advantage of this kind of specific chemical tuning of interactions, particularly 
in a position dependent way. Previously, this laboratory has investigated the nature of 
nonspecific or unstructured binding between proteins and surfaces covered with 
particular peptide sequences by exposing in situ synthesized peptide arrays to protein 
solutions. Such arrays provide effective tools for characterizing the interaction of 
biological macromolecules with surfaces because they present a set of sequences with 
great chemical complexity that can be precisely controlled. In that study, two individual 
proteins, β-galactosidase and α1-antitrypsin, as well as a mixture of 9 different proteins, 
were bound to arrays of nearly 5000 different short peptides with a wide range of charge 
characteristics, hydrophobicities and peptide lengths[12].  Interestingly, even very short 
sequences (tripeptides, tetrapeptides) covering surfaces discriminate strongly between 
different proteins or between individual proteins and mixtures of proteins.   While the 
general charge and hydrophobicity of the peptides are certainly important factors, more 
subtle aspects of the sequence are also important in driving the relative ability to bind one 
protein over another. From a practical point of view, the work demonstrated that it was 
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possible to simply and efficiently select short peptide sequences, directly on a surface, 
that dictated whether a particular protein would bind or not.   
The fact that even short surface-bound peptides can have both strong and selective 
interactions with proteins is important from a practical point of view; short peptides are 
relatively easy and inexpensive to use for surface modification.  Indeed, it is not 
unreasonable, given the size of peptide arrays now available, to perform essentially 
complete searches of tri-peptide and tetra-peptide and even penta-peptide sequence 
spaces to find the desired surface binding characteristics for the specific proteins, 
mixtures of proteins and/or conditions of interest.  This brings up the question of to what 
extent the properties of short peptide sequences can be added together, creating longer 
sequences with composite binding function. For example, if one stacks two tetra-peptides 
that both bind a particular protein selectively, does the affinity and selectivity increase 
accordingly? Similarly, if one builds a new peptide library on top of a short peptide 
sequence with known binding characteristics, does one find that the same peptide 
sequences that work well at the surface in enhancing interaction also serves the same 
purpose at the N-terminus of a nascent peptide chain? Here, a series of tetra-peptide 
motifs, identified in the previous work cited above, and known to bind β-galactosidase, 
will be examined as individual motifs, in combination with each other, and after 
extension with a library of additional sequences.   
It is important to note that the goal of the work described here is quite different 
from a study in which one is selecting a strong-binding ligand from a large library of 
possible peptides.  The goal is instead to understand how modifying surfaces with a 
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relatively dense attachment of peptide sequences changes its affinity for proteins and 
protein mixtures, and how this depends on the details of the peptide sequences.   
MATERIALS AND METHODS 
Peptide microarray fabrication 
The peptide microarrays used here were fabricated by LC Sciences (Houston, TX) 
using PepArray™ technology. The technology is developed based on proprietary 
µParaflo® microfluidics technology, which allows direct synthesis of peptides on a high 
density microfluidic chip (4000 features in a ~1.5cm2 area) as features in specific 
locations on the chip using a photogenerated acid (PGA) to deprotect the amines of 
nascent peptides and conventional t-boc solid phase peptide synthesis [13, 14]. The chip 
is actually an enclosed microfluidic system, which contains fluid distribution channels 
and picoliter scale reaction chambers with physical isolation from each other[13]. Each 
chamber contains one specific peptide sequence. The in-situ peptide synthesis consists of 
the following steps: (1) derivatization of the surface with a protected NH2-linker, 
resulting in a surface density of less than 1pmol per 1mm2 area; (2) applying a solution of 
the PGA precursor in dichloromethane; (3) deprotecting the protected amine in the 
desired reaction chamber using digital photolithography, which allows programmable 
light activation of chemical reactions; (4) coupling the amino acid, capping any unreacted 
linkers and deprotecting the side chain using standard peptide synthesis procedures [14-
17].     
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Peptide libraries synthesized on peptide array surfaces 
Two different peptide libraries were designed and synthesized on the arrays to 
study the relationship between sequence position within a peptide and binding affinity for 
β-galactosidase (see Results). The same set of 7 amino acids {E, L, S, R, Q, W, Y} as in 
the previous studies was used to synthesis all peptides [12, 18, 19]. Each peptide library 
contains 3918 custom-made peptides (including test sequences and control sequences), 
up to 8 amino acids in length, and 82 additional control spots (including blank and LC 
Science internal controls) provided by the company. Two identical arrays were made for 
each peptide library and each was bound under the same binding condition, but with 
samples labeled with different dyes (see below). A GSG tri-peptide linker was added to 
the C terminus of each sequence to maintain a uniform linkage between the peptides and 
the array surfaces in addition to the proprietary surface linker (20-30nm in length) used 
by LC Sciences. 
The first set of peptide arrays (“extension arrays”) included peptide sequences 
with the following motifs: “(N’) X abcd GSG (C’)”; “(N’) XX abcd GSG(C’)”; “(N’) 
XXX abcd GSG(C’)”. The C-terminal “abcd GSG” sequence was one of 8 sequences 
selected from a peptide library that included all possible variations of the tetrapeptide 
sequence “abcd” created in a previous study using the same sub-set of 7 amino acids 
specified above[12].  The sequences used are given in Table 3.1.  For both the previous 
array and the arrays described here, the peptide sequences are attached to the surface via 
the C-terminal glycine. These selected tetrapeptides (actually a selected tetrapeptide plus 
the GSG linker) were chosen so that between them they cover a range of affinities to β-
galactosidase.  The N-terminal “X, XX and XXX” segments constitute all possible 
78 
sequence combinations with one amino acid (7 combinations), two amino acids (49 
combinations) and three amino acids (343 combinations), using the 7 different amino 
acids specified above. All possible combinations of the eight different “abcd” tetrapeptide 
sequences and the “X, XX, XXX” N-terminal sequences were synthesized in the same 
arrays. In addition, all of the one amino acid, two amino acid and three amino acid N 
terminal extensions themselves were synthesized directly on a GSG linker (e.g., “(N’) 
XXX GSG (C’)”) as were the eight base tetrapeptide sequences without further extention 
(“(N’) abcd GSG (C’)”). The base tetrapeptide sequences were synthesized with 10 
replicates. The library also contains 319 peptides randomly selected from previous arrays 
to monitor the chip-to-chip variation.  
The second set of peptide arrays (“concatenation arrays”) included peptide 
sequences with the motif: “(N’) xxxx yyyy GSG (C’)”.  Both of the “xxxx” and “yyyy” 
were sequences chosen from 57 tetrapeptides again selected from the previous study of 
all tetrapeptide sequences.  The 57 sequences used in this study were chosen by 
performing ‘K-mean’ clustering of the binding data from all tetrapeptide sequences into 6 
groups depending on the level of apparent affinity and relative specificity to β-
galactosidase, and then selecting sequences that covered all 6 groups. The sequences of 
the peptides that make up the arrays in the second set consist all possible combinations of 
two of the 57 tetrapeptide peptide sequences, spliced together in the motif described 
above. The individual 57 tetrapeptides used in this study were also included on the array 
as controls in the form “(N’) xxxx GSG (C’)”. In addition, the library contained 669 
peptides randomly selected from previous arrays to monitor the chip-to-chip variation 
and normalization. 
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Protein binding 
 Alexa Fluor®-555 and Alexa Fluor®-647 (AF555 and AF647, Invitrogen/Life 
Technologies) labeled proteins were used for the protein binding assays. The labeling 
process followed the standard protocol provided by the manufacturer for the dye 
(Invitrogen/Life Technologies). Proteins used in the experiments here were the same as 
the proteins used in previous studies with the exception of α1-antitrypsin, which was 
added to the protein mixture instead of being tested as an individual protein [12]. (Note 
that while α1-antitrypsin is known to bind its reactive center loop (FLGAIG) peptide [20-
23], and one might be concerned this specific binding would bias the peptide binding of 
the protein mixture, previous work from this lab [12] has not shown such a peptide bias 
in these arrays and in fact the dependence of binding on charge and hydrophobicity of 
this protein is very similar to the overall protein mixture). Two different binding 
concentrations, 10nM and 100nM, were tested for β-galactosidase (from E.coli). The 
concentration for each protein in the mixture was then determined using the same 
approach as in previous experiments [12]. The dye/protein labeling ratio for each protein 
was also maintained as previously. The fluorescent signal from the bound labeled 
proteins was measured and used as an indicator for peptide protein binding activity 
(referred to as the binding signal below). The concept of dye-swapping (labeling with two 
dyes and testing to see if binding is driven by the specific dye or by the protein) was 
employed as previously [12]. Protein samples separately labeled with AF555 and AF647 
were applied on identical arrays respectively under the same experimental conditions. 
Very similar results were obtained regardless of which dye was used (e.g., Figures S3, 
S4, S5 and S6).  For the extension study, binding signals from the array with AF555 
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labeled β-galactosidase were used, due to a problem with one of the AF647 arrays, while 
for the concatenation studies, binding signals from proteins with the two dye labels were 
averaged.  
The actual protein binding assays were performed by LC sciences using the 
following procedures and conditions (procedures and conditions are from LC Sciences 
final customer reports). First, the chips were blocked in the blocking buffer (super block, 
a proprietary blocking solution, with 0.05% Tween-20 and 0.05% Triton X-100, pH7.0), 
overnight at 4ºC, to minimize non-specific binding and then washed in washing buffer 
(1×PBS, pH 7.0). Second, two different protein samples (AF555-β-galactosidase and 
AF647-β-galactosidase,) were bound to two identical arrays respectively for 1 hour in 
binding buffer (1×PBS, pH7.4) at 25°C, then washed with washing buffer. The array was 
then imaged using either 635 nm excitation and a 655-695 nm emission filter or 532 nm 
excitation and a 550-600 nm emission filter, depending on the dye used. The arrays were 
adapted to fit into standard Molecular Devices GenePix scanner and the PMT voltage 
level was adjusted based on a pre-scan image. After recording the first image, the chip 
surface was stripped with stripping buffer cocktail (pH7.0) at 25°C for 2 hours to remove 
surface-bound proteins, and then washed in washing buffer. The chips were imaged again 
at the same wavelength to confirm the stripping. Fourth, the AF555-protein mixture was 
bound to the stripped array that had AF647-β-galactosidase and the AF647-protein 
mixture was bound to the stripped arrays that had AF555-β-galactosidase for 1 hour in 
binding buffer at 25°C, then washed with washing buffer. The array was then re-imaged 
for AF647 fluorescence. Note that an advantage of using β-galactosidase for these studies 
is its large size.  There should be very little interaction between dyes on different 
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proteins.  As a result, binding signals should be linear with the concentration of β-
galactosidase. 
Data analysis 
The binding between protein and peptides is measured as the fluorescence 
intensities of dye-labeled proteins captured by surface bound peptides. Higher 
fluorescence intensities suggest higher protein binding to a particular peptide feature. The 
term “binding signal” is used in all subsequent descriptions to refer to the measured 
fluorescence intensity. Peptide binding signal values were provided for each feature by 
LC Sciences as the median fluorescence intensity for each peptide feature. The 
background level, which is generally ~5% -10% of the lowest binding signal, depending 
on the sample used, was also provided by the company in the data report. For all of the 
analysis reported here, the binding signal for each peptide was normalized to the median 
intensity of each array [24]. Binding signals from arrays bound with same sample but 
using different dye labels were averaged and the mean of the binding signals was used in 
further analyses. Locally written scripts in Matlab were used to sort the peptides and to 
perform statistics.  
 
RESULTS 
Tetrapeptide extension studies 
A set of arrays (“extension arrays”) was designed to explore how the affinity of a 
tetrapeptide (the “base tetrapeptide) for β-galactosidase changes when it is extended by 
all possible one, two or three amino acid sequences (the “extension sequence).  
Specifically the question is how the binding properties of the base tetrapeptide alone 
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combine with the binding properties of the extension sequence to generate the binding 
properties of the extended peptide sequence (the “extended peptide sequence” is the base 
tetrapeptide plus the extension sequence). The binding signal distribution after incubating 
β-galactosidase with these arrays is shown Figure 3.1. As can be seen, in most cases, 
there is a rather wide distribution of binding signals associated with each family of 
extended peptide sequences (a family being defined by its base tetrapeptide sequence).   
 
Figure 3.1.  Three dimensional histogram of β-galactosidase binding signal 
distribution resulting from the extension of selected 8 tetrapeptides with 1, 2 or 3 
amino acids. For the base tetrapeptdies EYEY, RLLY, RYLY, YRRE and RQYY, the 
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peptides with low binding signal (essentially background) dominate and have fractional 
values exceeding the height of the y-axis (indicated by arrows).  For example, for the 
base tetrapeptide EYEY, all of the extension peptides are in the “0” bin because their 
binding is at background levels (this bin has a vertical value of 1).  The tetrapeptide 
groups were ordered by their inherent binding affinities to β-galactosidase without 
extension (highest on left).  The binding signals for the base tetrapeptide sequences alone 
are shown in Table 3.1, but in each case they are near the median of the distributions 
shown. All binding signal values were normalized to the global median. 
Table 3.1 shows that, roughly speaking, the average binding signal of all extended 
peptide sequences derived from a particular base tetrapeptide has a value similar to the 
binding signal of the base tetrapeptide sequence itself.  Another way to visualize these 
results is shown in Figure 3.2.  Here, the average β-galactosidase binding signal for all 
extended peptide sequences with the same base tetrapeptide sequence is plotted versus 
the binding signal of the base tetrapeptide sequence alone. Apparently, on average, 
addition of an extension sequence to the base tetrapeptide is as likely to reduce as to 
increase the affinity of the base tetrapeptide sequence for β-galactosidase.  
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Figure 3.2. β-galactosidase average binding signal for the extended peptide 
sequences vs the inherent binding signal of the base tetrapeptide sequence alone. 
The fluorescence intensities (AF555- β-galactosidase) of the 399 extended peptide 
sequences for each base tetrapeptide sequence were averaged.  All intensities were 
normalized to the global median. The error bars shown represent the standard error of the 
mean for that base tetrapeptide group. 
Even though the base tetrapeptide appears to dictate the average binding to β-
galactosidase of all the extended tetrapeptides, it is clear from Figure 3.1 that some 
extended tetrapeptides bound much more strongly or weaklly than the corresponding 
non-extended tetrapeptide.  Table 3.1 shows the average binding signal for both the 10 
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elongated peptides with the highest affinity derived from each base tetrapeptide sequence 
and for the 10 elongated peptides with the lowest affinity for each base tetrapeptide 
sequence. In some of the cases in which binding to the base tetrapeptide sequence alone 
was weak, the highest affinity extended tetrapeptide sequences increased binding signal 
by as much as ~18-fold. Weak-binding base tetrapeptide sequences containing negatively 
charged residues (EYEY and YRRE) were not improved as much by extension as neutral 
or positive sequences.  Base tetrapeptides that were strong binders alone also showed less 
apparent improvement.  However, this appears to be an issue of dynamic range of the 
experiment.  For peptides based on these high affinity base tetrapeptide sequences, there 
was relatively little change in binding signal when 100 nM β-galactosidase was used 
instead of 10 nM (i.e., binding was nearly saturated).  Technically, it was difficult to find 
a concentration range in which the top end of the binding signal was not close to 
saturation, but the bottom end was still measurable in the same experiment.  Trying to 
compare values between arrays that used different concentrations of protein added 
enough to the noise in the data so that it was not reliable.  Note that for the tetrapeptide 
sequence EYEY, the binding is always essentially at the level of the background signal.  
Thus while the measured improvement due to extension is small, it is not clear whether 
this is because of lack of improvement or because the binding is so weak to begin with 
that the improvement is not sufficient to raise the signal above the background. 
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Table 3.1.Binding information for base tetrapeptides and extended sequences 
Base 
Tetrapeptid
e 
Net charge 
for base 
tetrapeptid
e  
Base 
tetrapeptide 
binding 
signal to ß-
galactosidas
e 
Average 
binding of 
the 
elongated 
peptides 
with the 
same base 
tetrapeptid
e 
Average 
binding of 
the top 10 
elongated 
peptides 
with the 
same base 
tetrapeptid
e 
Average 
binding of 
the bottom 
10 
elongated 
peptides 
with the 
same base 
tetrapeptid
e 
EYEY -2 0.40±0.01* 0.4 0.64±0.02 0.32±0.01 
RLLY 1 0.55±0.03 1.5±0.1 8.3±0.4 0.34±0.02 
RYLY 1 0.58±0.03 1.9±0.1 10.5±0.3 0.34±0.01 
YRRE 1 0.61±0.04 1.01±0.04 4.2±0.1 0.34±0.02 
RQYY 1 0.65±0.04 2.1±0.1 9.2±0.1 0.36±0.03 
SYRS 1 5.8±0.3 6.4±0.2 12.9±0.2 0.94±0.36 
YSRS 1 6.1±0.5 6.7±0.1 12.1±0.1 1.6±0.5 
YSRR 2 7.9±0.3 7.2±0.1 12.5±0.2 1.4±0.5 
*Errors are represented in text as ± standard error of the mean 
The effect of the length of the extension was also considered. There is very little 
difference in the average binding signal of all base tetrapeptides extended by one, two or 
three amino acids (Figure S3.1).  However, the 10 highest binding signals for the three 
amino acid extensions is ~2 fold higher than for one amino acid extensions and ~1.2 fold 
higher than two amino acid extensions.  Thus while the average binding signal is not very 
sensitive to the length of extension, the absolute value of the extent of change is.  This 
could be an effect of length per se, or it could be simply that there are more three amino 
acid extensions to choose from than two amino acid or one amino acid extensions 
(increased sequence complexity).  
As described above, extension can either reduce or increase the affinity of a 
particular tetrapeptide sequence for β-galactosidase. One question is whether there is a 
discernible sequence dependence of extension on binding.  One might expect that 
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extending a base tetrapeptide sequence with an extension sequence of one to three amino 
acids that by itself is a strong binder would lead to an extended peptide sequence with 
increased binding affinity.  Conversely, adding an extension sequence that binds β-
galactosidase only weakly by itself might be expected to lower the binding affinity of the 
extended peptide sequence.  Figure 3.3 shows the result of plotting the average binding 
signal of the extended peptide sequences that used a particular one, two and three amino 
acid extension sequence vs. the inherent binding of the extension sequence alone.  Note 
that each point in the plot is the average of the eight possible extended sequences made 
from a particular extension sequence and one of the eight base tetrapeptide sequences. 
There is a correlation between the binding signal of the extension sequence alone and the 
binding of the average extended peptide sequence, but it is less pronounced than that 
between the binding signal of the base tetrapeptide alone vs. the average signal from the 
extended peptide sequence in Figure 3.2.  This may be due in part simply to the size of 
some of the extensions: when added to a tetrapeptide, a single amino acid is unlikely to 
have as dramatic an effect as a larger sequence, particularly on the low end of the binding 
scale. 
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Figure 3.3. β-galactosidase average binding signal for the extended peptide 
sequences vs the inherent binding signal of the extension sequence alone.. The 
binding signals (AF555- β-galactosidase) from peptides with the same N-terminal 
extension sequence were averaged together. For each N-terminal extension sequence, 
there were 8 peptides. Binding signals shown were normalized to the global median. The 
error bars shown represent the error in the mean for each N-terminal extension sequence 
group.  
To explore this issue further, extended sequences with the highest and lowest 
binding signals for β-galactosidase were compared to the highest and lowest signals seen 
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for the extension sequences by themselves.  Of the extended peptide sequences with the 
top 10% of binding signals, about half of these included extension sequences that ranked 
in the top 10% of the binding signals from extension sequences themselves.  Similarly, of 
the extended peptide sequences with the bottom 10% of binding signals, about a quarter 
of these included extension sequences that ranked in the bottom 10% of the binding 
signals from extension sequences themselves.  Thus there is a statistical bias for the 
extension sequences with the greatest inherent affinity for β-galactosidase to be present in 
the extended peptide sequence with the greatest β-galactosidase affinity. 
Figure 3.4 considers in more detail the amino acid composition of the sequences 
of the extended segments themselves.  The charge characteristics of the amino acids used 
in the N-terminal extension sequences is the most important factor in determining binding 
to β-galactosidase.  This is also true of the extension sequences by themselves.  Figure 
3.4 shows a heatmap of the amino acid composition of the extension sequence added to 
different base tetrapeptides that gave rise to extended peptide sequences with binding 
signals in the top 10%. The amino acid composition values were determined from the 
ratio of the amino acid’s frequency of occurrence in top 10% of binding sequences 
divided by its frequency of occurrence in all extended sequences. A similar heatmap for 
the bottom 10% of the binding sequences is not shown but is essentially the reverse of 
Figure 3.4. As one might expect given the low pI of β-galactosidase (4.61), the positively 
charged amino acid, arginine, occurs in almost all strong binding sequences, while the 
negatively charged amino acid, glutamic acid, occurs in almost all weakly binding 
sequences. Perhaps of more interest, tyrosine has a somewhat elevated frequency of 
occurrence in the top 10% of binding sequences while glutamine and serine have a higher 
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likelihood of being in the bottom 10% of the binding sequences.  The composition of 
amino acids that gave rise to a strong enhancement of binding when added to the N-
terminus of the tetrapeptide “EYEY” was quite different from that of extensions from the 
other base tetrapeptides, however the signal is so low for this base tetrapeptide alone that 
calculation of enhancement factors is subject to substantial noise.   
 
Figure 3.4. A heatmap of the relative frequency of specific amino acids in the 
extension sequences. The y-axis shows the different base tetrapeptides used (“Surface” 
means there was no tetrapeptide; amino acids were added directly to the linker on the 
surface).  Each column represents a different amino acid used in the extension sequence.  
Each row represents a different base tetrapeptide.  The color represents the relative 
frequency of occurrence of a particular amino acid in the highest binding 10% of the 
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extension sequences built on the base tetramers.  A color value of “1.0” represents a 
frequency of occurrence of a particular amino acid equivalent to that expected from a 
randomly defined sequence (1/7 since there are seven different amino acids used). 
Relative specificity, the tendency to bind one protein vs. another, was explored by 
comparing the binding of β-galactosidase protein to the binding of a mixture of 10 
different proteins (these were the same proteins used in a previous study of protein 
binding to ordered peptide libraries plus α1 antitrypsin [12]).  When the relative 
specificity is plotted against the binding signal, a strong correlation between affinity and 
relative specificity for these peptides is observed (data not shown), as was found 
previously in studies of β-galactosidase to peptide libraries[12]. Normalizing the data of 
Figures 3.2 and 3.3 to the intensity of the mixture of 10 proteins did not appreciably 
change the trends, again suggesting that binding and relative specificity track. Table 3.2 
shows the relative specificity values for the base tetrapeptides and the elongated peptide 
sequences.   As one might expect, the most specific base tetrapeptides give rise to most 
specific extended peptide sequences. 
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Table 3.2. Relative specificity for base tetrapeptides and extended sequences 
Tetrapeptide Net charge 
Relative 
specificity to ß-
galactosidase 
Average 
relative 
specificity of all 
elongated 
peptides 
Average 
relative 
specificity of 
the top 10 
elongated 
peptides 
EYEY -2 0.56±0.02* 0.65 0.95±0.03 
RYLY 1 0.67±0.03 0.90±0.03 0.7±0.1 
RLLY 1 0.67±0.04 1.2±0.1 3.9±0.2 
YRRE 1 0.75±0.04 1.24±0.03 3.7±0.1 
RQYY 1 0.76±0.03 1.01±0.03 3.1±0.1 
SYRS 1 2.0±0.2 3.8±0.1 7.3±0.2 
YSRS 1 2.4±0.3 3.9±0.1 6.6±0.1 
YSRR 2 2.8±0.2 4.7±0.1 9.1±0.3 
*Errors are represented in text as ± standard error of the mean 
 Finally, the effect of amino acid order in the extension sequences on binding was 
considered in the case of 3 amino acid extensions.  Extended peptide sequences in which 
a particular amino acid was in the first, second or third position were averaged to try and 
understand if sequence or composition was more important in the effect of the extension 
sequence.  What was found was that the effect of a particular amino acid, on average, was 
largely independent of where it was placed (data not shown).  Thus, composition of the 
extension sequence appears to be more important than the actual order of amino acids.  
Concatenation Arrays 
A set of 57 tetrapeptides (“component tetrapeptides”) were selected as described 
in Materials and Methods and all possible pairs were concatenated to form 3249 different 
sequences (“concatenated sequences”) of the form “(N’) xxxx yyyy GSG (C’)”.  The 
objective of this study was to explore how the affinity of each concatenated sequence 
relates to the known affinities of its component tetrapeptides and to what extent the order 
of those component tetrapeptides matter. Figure 3.5 shows the average binding signal 
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from the concatenated peptides that have a particular C-terminal component tetrapeptide 
sequence (“yyyy” above) versus the inherent binding signal of that individual C-terminal 
component tetrapeptide alone. The correlation between the average binding signal for the 
concatenated sequence and the average binding signal for its C-terminal component 
tetrapeptide is very strong (almost 1 to 1).  
 
Figure 3.5. β-galactosidase average binding signal of the concatenated 
sequences vs. the inherent binding signal of the C-terminal component tetrapeptide 
sequence alone. The average of the binding signals from all 57 peptides containing a 
particular C-terminal component tetrapeptide sequence are shown as a function of the 
binding signal from the C-terminal component tetrapeptide by itself. Intensity values 
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shown are normalized to the global median and signals from both AF555 and AF647 
labeled protein binding measurements were averaged. The correlation is very similar 
when either dye labeled protein measurement is considered separately, implying that 
binding is not very dependent on the dye (Figs S3 and S4).  
Figure 3.6 shows the average binding signal from the 57 concatenated peptides 
with a particular N-terminal component tetrapeptide sequence (“xxxx” in the motif 
defined above) plotted as a function of the inherent binding strength of that N-terminal 
component tetrapeptide sequence alone.  In contrast to Figure 3.5, the dependence is 
weak, suggesting that a sequence that was originally selected to bind well a particular 
distance from the C-terminus of the peptide (which is where the peptide is attached to the 
surface) does not necessarily contribute strongly to binding when displaced from the 
surface.  In addition to the weaker correlation shown in Figure 3.6, the set of 
concatenated peptides that have the same component tetrapeptide sequence at N-terminus 
exhibit a different binding dynamic range than the set of concatenated peptides with that 
same component tetrapeptide sequence at the C-terminus. More specifically, the standard 
deviation of the binding signals of concatenation peptides that have a particular C-
terminal tetrapeptide sequence is 0.63 while the standard deviation in the binding of 
families of sequences with the same N-terminal component tetrapeptide is 1.07; grouping 
sequences by their N-terminus is much more variable that grouping sequences by their C-
terminus. This again implies that the position of the binding sequence relative to the 
surface affects the nature of its contribution to the binding signal. 
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Figure 3.6. β-galactosidase average binding signal of the concatenated 
sequences vs. the inherent binding signal of the N-terminal component tetrapeptide 
sequence alone.  The average binding signals from all peptides that contain a particular 
N-terminal component sequence were plotted as a function of the average binding signal 
of the N-terminal component sequence alone. Intensity values shown are normalized to 
the global median and the binding signals of AF555 and AF647 labeled proteins were 
averaged. Either dye-bound protein gives a very similar binding trend (Figs S5 and S6).  
 The effect of charge on peptide binding was also explored in the concatenation 
studies. β-galactosidase has a pI of 4.61, and thus is negatively charged at neutral pH.  
96 
Therefore, one would expect that peptides with positive charges have higher binding 
signal in general. Consistent with this expectation, the concatenated peptides with a 
negatively charged component tetrapeptide on either the N-terminus or C-terminus show 
relatively weak binding to β-galactosidase. This trend is a little more pronounced when 
the negatively charged component tetrapeptide sequence is placed near surface at C-
terminal. As was seen for the extension study, concatenation of an N-terminal component 
tetrapeptide to a negatively charged C-terminal component tetrapeptide hardly increases 
binding to β-galactosidase at all, regardless of how strongly the N-terminal component 
tetrapeptide sequence binds by itself.  
The relative specificity of β-galactosidase binding was also studied for the 
concatenation library.   Similar to the extension studies, when the relative specificity is 
plotted against the binding signal, a strong correlation between affinity and relative 
specificity is observed (data not shown). There is no significant change in correlations 
when the data of Figures 3.5 and 3.6 are normalized to the intensity of the mixture of 10 
proteins (data not shown).  
DISCUSSION 
Traditionally, the focus of molecular recognition studies in biology has been on 
so-called specific interactions.  In general, nonspecific interactions are largely ignored or 
considered uninteresting.  However, by definition, any macromolecule in the cell 
undergoes many more nonspecific than specific interactions with molecules and 
particularly molecular surfaces around it.  Indeed, as our understanding of the crowded 
environment of the cell increases, it has become more and more apparent how important 
controlling such interactions in both time and space are.  This is thought to have been a 
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significant constraint in the evolution of protein structure [25, 26].  In this regard, 
“specific” and “nonspecific” are really misnomers.  A more precise nomenclature is 
“structured” and “unstructured” interactions; the difference between them being whether 
a certain metastable structure is formed (a narrow potential well) or whether the affinity 
is driven by longer range forces or by a summation of many interactions that allow for 
multiple relative positions of the binding pair (a broad potential well). 
Classical approaches to understanding what forces and types of chemical 
interactions are involved in structured interactions often do not work well for 
unstructured interactions due to the heterogeneity of the system.  Instead, statistical 
approaches can be used, and the systematic analysis of binding to diverse arrays of 
binding partners is one such approach.   The studies described above were built on earlier 
work in which a comprehensive analysis of tetrapeptides binding to a common protein, β-
galactosidase, was performed, resulting in a catalogue of peptide sequences and relative 
affinities[12].  This made it possible to ask several simple, fundamental questions about 
the nature of unstructured interactions: 
 Is the binding of the component motifs additive? 
 Does the order or context of the binding motifs matter? 
 What kinds of intermolecular forces dominate binding to β-galactosidase? 
 Does additive binding result in additive specificity? 
β-galactosidase is well suited for this study as it is a protein with a large, diverse surface 
area that does not have known natural peptide binding partners.  This increases the 
likelihood of finding unstructured binding interactions with the peptide covered surfaces.   
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Additivity.  In the first set of experiments described above, extending a tetrapeptide motif 
by one, two or three amino acids resulted in both increases and decreases in overall 
binding of β-galactosidase, as shown in Figure 3.1.  In general, the ability of the 
extension sequences to increase or decrease the binding of the base tetrapeptide 
correlated weakly with the binding of the extension sequence alone (Figure 3.3).  The 
shallow correlation is particularly evident if one excludes the very weakest binding 
peptides (<1 on the scale given in Figure 3.3).  The weak additivity is even more apparent 
when two component tetrapeptide sequences that have been tested independently for 
relative affinity are concatenated together.  As shown in Figure 3.6, simply adding a high 
affinity sequence to the N-terminus of another sequence of known relative binding 
affinity does not increase binding affinity substantially on average.  Thus, while adding 
sequences to the N-terminus of a known binder can indeed either enhance or reduce 
binding by a large factor (see Tables 3.1 &3.2 and associated text), that change does not 
correlate well with the affinity of that N-terminal addition when it is attached directly via 
the GSG linker to the surface. 
Order or Context.  Figures 3.2, 3.3, 3.5 and 3.6 address the question of position or order 
of binding sequences.  In Figures 3.2 and 3.5, there is a strong, and nearly one to one, 
correlation between the relative affinity of the C-terminal sequence and the average 
relative affinity of the extended or concatenated sequences.  In Figures 3.3 and 3.6, the 
correlation with the N-terminal sequence is considerably weaker.  In other words, the 
binding contribution of the C-terminal tetrapeptide remains more or less constant, 
regardless of what is added to it, and the relative affinity of the sequence added is not 
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very predictive of overall affinity. Thus the order or context of the binding motif is 
critical in determining its contribution to the binding in these surface attached peptides. 
Forces.  Forces that drive unstructured interactions can be any of a number of non-
covalent forces including charge-charge, hydrophobic or hydrogen bonding interactions. 
Here, charge-charge interactions appear to play the dominant role in determining the 
binding activity for β-galactosidase (a very negatively charged protein). This is reflected 
in Figure 3.4 which shows that β-galactosidase prefers Arg, a positively charged residue, 
to any other amino acid for extending a tetrapeptide motif by one, two or three amino 
acids. The importance of charge-charge interactions has been confirmed in previous 
studies in which β-galactosidase binds strongly and selectively to some of the most 
positively charged peptides[12].  Because of its large size, there is more opportunity for 
long-range interactions, like columbic interactions to take place.  In addition, because of 
its low pI, it is strongly negatively charged at neutral pH; there are approximately 97 
aspartic acid residues and 135 glutamic acid residues exposed to the solvent.  This makes 
it very easy to form charge-charge interactions with positively charged peptides. The fact 
that extension of peptides with tyrosine-containing sequences appear to enhance binding 
could suggest a role for hydrogen bonding, but additional comparison (e.g. to 
phenylalanine that was not included in this study) would be necessary.  
Specificity. In both experiments performed here, the relative specificity values for β-
galactosidase are strongly correlated to its binding affinity values. In other words, the 
ratio between β-galactosidase binding and the binding of a diverse set of ten other 
proteins increases and decreases in essentially the same way as does the affinity. Thus, 
extension sequences that result in more affinity usually result in more specificity. Clearly, 
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unstructured interactions between proteins and surface bound peptides can be quiet 
selective in some cases as shown by β-galactosidase, making it possible to create 
complex patterns of relatively short peptides on surfaces that are capable of quite 
selective interactions with different proteins.  
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SUPPORTING INFORMATION 
The effect of the length of the N terminal extension  
The effect of the length  of the N terminal extension was studied by plotting the average 
β-galactosidase binding signal for one, two  and three amino acid extended peptide 
sequences (each point is an average over all extended peptide sequences with a particular 
base tetrapeptide sequence) versus the binding signal for the base tetrapeptide alone 
(Figure S3.1).  The average binding signals are not substantially different as a function of 
extension length, though as described in the main text, the extended peptide sequences 
that show the highest binding signals have three amino acid extensions.  In other words, 
the effect of the extension at any length is more or less equal in either direction 
(increasing or decreasing the binding signal), but the absolute value of the effect is 
greater with longer extensions. 
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Figure S3.1 β-galactosidase average binding signal for the one, two and three amino acid 
extended peptide sequences vs. the binding signal of the base tetrapeptide sequence upon 
which the extended sequences were built. Details as in figure 3.2.  
 
The effect of dye-driven binding  
To moniter the effect of dye-bias on protein binding, a dye-swaping expereiment was 
performed using AF555 labeled β-galactosidase on one array and AF647 labeled β-
galactosidase on another identical array under the same binding conditions at the same 
time. Figure S3.2 shows the results of plotting the binding signal from each feature in the 
array using AF555 labeled protein vs. the same feature in the array using AF647 labeled 
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protein. In general, the distribution of intensities is what one might expect for a protein 
dominated binding interactions; almost all of the peptides that give high binding with one 
dye label also give high binding with the other.  To specifically address the question of 
whether dye binding is affecting the results of this study, Figures S3.3, S3.4, S3.5 and 
S3.6 show the average binding signal from the concatenation peptides that have a 
particular C (or N)-terminal base tetrapeptide sequence versus the inherent binding signal 
of that individual C (or N)-terminal tetrapeptide alone using either binding data from 
AF555 (Figures S3.3 and S3.4) or AF647 (Figures S3.5 and S3.6) labeled β-
galactosidase. The binding trends and conclusions one would draw are very simialr to 
what was observed with the average binding data of AF555 and AF647 labeled β-
galactosidase (Figure 3.5 and Figure 3.6).  This indicates that the dye-bias effect is not 
the driving force in the binding trends observed here.  
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Figure S3.2 AF555 labeled beta-galactosidase binding intensity versus AF647 
labeled beta-galactosidase binding intensity. The fluorescent signals from the bound 
labeled proteins were measured and normalized to the global median on each array. A 
linear regression was performed between two groups and the binding signal ratio between 
two labeled proteins was calculated. Points that have a ratio smaller than 0.5 or larger 
than 2.0 are represented by red circles.  While there is likely some dye-driven binding, 
the vast majority of the signal appears to correlate well between the two arrays, given a 
Pearson correlation coefficient of 0.74. 
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Figure S3.3 The average binding signal from AF555 labeled β-galactosidase incubated 
with concatenated peptides sharing the same C-terminal base tetrapeptide sequence 
versus the inherent binding signal of the C-terminal base tetrapeptide sequence alone. 
This plot is identical to Figure 3.5 except that only AF555 labeled β-galactosidase was 
used. 
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Figure S3.4 The average binding signal from AF647 labeled β-galactosidase incubated 
with concatenated peptides sharing the same C-terminal base tetrapeptide sequence 
versus the inherent binding signal of the C-terminal base tetrapeptide sequence alone. 
This plot is identical to Figure 3.5 except that only AF647 labeled β-galactosidase was 
used. 
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Figure S3.5  The average binding signal from AF555 labeled β-galactosidase incubated 
with concatenated peptides sharing the same N-terminal base tetrapeptide sequence 
versus the inherent binding signal from the N-terminal base tetrapeptide sequence alone. 
This plot is identical to Figure 3.6 except that only AF555 labeled β-galactosidase was 
used. 
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Figure S3.6  The average binding signal from AF647 labeled β-galactosidase incubated 
with concatenated peptides sharing the same N-terminal base tetrapeptide sequence 
versus the inherent binding signal from the N-terminal base tetrapeptide sequence alone. 
This plot is identical to Figure 3.6 except that only AF647 labeled β-galactosidase was 
used. 
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Graphical Abstract 
 
Figure S3.7. Labeled β-galactosidase binding to an “extension array”. This is an 
example of the array images received from LC Sciences.  
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CHAPTER 4: EXPLORING THE NATURE OF PEPTIDE-ANTIBODY 
INTERACTIONS USING DIVERSE-SEQUENCE PEPTIDE ARRAYS 
CONTRIBUTION 
The following chapter describes a study that exploring the general interactions 
between antibodies and surfaces covered with peptides.  The binding of monoclonal 
antibodies and serum to the HealthTell array surface covered with particular peptides is 
systematically studied and the binding information is used to understand the chemistry of 
binding. The array synthesis and binding assays were performed by HealthTell and by the 
CIM peptide array core. For each peptide feature, the raw binding signal from the binding 
assay is the median intensity of each spot on the array. Wei Wang took the raw binding 
data and performed the analysis of the binding data as described below.   
INTRODUCTION 
Antibody-antigen reactions are widely used both clinically and in the laboratory 
to detect the level of biomarkers or pathogens in human serum associated with a variety 
of diseases.  In a number of cases the antibody raised in response to the disease itself 
serves as a key biomarker [1, 2]. The Center for Innovation in Medicine in the Biodesign 
Institute at Arizona State University has developed an approach for profiling the 
repertoire of circulating antibodies in the blood that utilizes high density peptide arrays. 
Specifically, human serum containing  large amount of antibodies is applied to the 
surface of an array of thousands of diverse-sequence peptides and the binding of blood-
borne antibodies to these peptides can be measured in terms of the fluorescence intensity 
of a labeled secondary antibody. The resulting so-called immunosignature, the pattern of 
binding of antibodies to the diverse-sequence peptide features in the array, can both 
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detect and identify a wide variety of specific diseases[2]. There are several published 
studies using immunosignatures to characterize vaccines[3] and it has been successfully 
applied to detection of such diseases as Alzheimer’s disease[4], various brain cancers[5], 
valley fever[6] and breast cancer[7].  The approach has also been used to simultaneously 
detect and discriminate multiple cancers as well as multiple infectious diseases[8, 9]. 
Results from these studies strongly suggest that the unique immunosignatures derived 
from the binding between antibodies and diverse-sequence peptides can reflect disease-
driven changes in the antibody profile and the approach is currently being 
commercialized as a diagnostic tool with HealthTell (www.healthtell.com).    
Although linear antibodies (antibodies that bind a contiguous sequence of amino 
acids) are known bind to specific epitopes, most antibodies also have substantial cross-
reactivity with non-cognate targets [10]. Moreover, using the immunosignature peptide 
arrays mentioned above, Halperin et al. have found that monoclonal antibodies can bind 
non-cognate peptide sequences with high affinity[11]. This suggests that the interactions 
between antibodies and these surface-bound peptides are not entirely driven by 
interactions with one specific sequence. In fact, when a paratope binds to its 
corresponding epitope, the initial interactions are thought to be driven by general long-
range forces, such as ionic and hydrophobic interactions. These attractive forces locally 
overcome the hydration energies and allow the epitope and the paratope to approach each 
other more closely. Once the surfaces of the paratope and epitope are close enough, a 
strong interfacial bond resulting from Van der Waals forces will arise and the strength of 
this bond is usually depends on how closely the two surfaces fit each other and the total 
contact area involved [12, 13]. While the specific interfacial interaction between a 
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paratope and a known epitope can be characterized in detail with crystallography, 
exploring the range and chemical nature of possible mimotope sequences is more 
difficult.  
Here, the interactions between antibodies and dense arrays of peptide features will 
be studied using peptide arrays that have been intentionally designed for measuring 
immunosignatures. The peptide arrays were manufactured using a photolithography-
based, in situ synthesis approach and each array consists of ~330,000 peptide sequences 
with an average length of ~12 amino acids (plus a three amino acid linker, GSG) and a 
length range from 3 to 17 amino acids[8]. Sixteen of the twenty natural amino acids were 
used in the synthesis (cysteine, methionine, isoleucine and threonine were excluded).  
The ~330,000 feature arrays each cover an area of ~0.5 cm2 and each feature in an array 
is 8 microns in diameter and contains a uniquely synthesized peptide sequence.  The 
peptide sequences were generated using a pseudo-random algorithm designed to 
minimize the number of synthesis steps but sample combinatorial sequence space fairly 
evenly[8].  
As described above, these arrays are being developed for health monitoring by 
profiling the pattern of molecular recognition of circulating antibodies in the blood.  In 
the context of that application, there are a number of fundamental questions about general 
interactions between antibodies and peptide affixed to surfaces that need to be answered. 
The antibody samples used here include both single, commercially available monoclonal 
antibodies as well as serum samples from either healthy individuals or individuals known 
to have a specific infectious disease (Malaria). In particular, two well characterized 
monoclonal antibodies (p53Ab1, one of the p53 epitopes and DM1A, an antibody against 
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tubulin), four normal serum samples and four disease serum samples were tested on 
immunosignature peptide arrays from two different manufacturing lots (the arrays are 
made on the surface of silicon wafers and the two sets of arrays used came from two 
different wafers made at different times). While the monoclonal antibody samples each 
contain a single type of immunoglobulin, the serum samples are heterogeneous mixtures 
of many biomolecules including a large diversity of different immunoglobulins. Antibody 
binding to different peptide features on the surface is visualized in each case through the 
use of a labeled secondary antibody to the constant region of the primary antibody (for 
the studies described below, a labeled secondary antibody to IgG was used).  The 
dynamic range of this binding is very high for both monoclonal antibodies and serum. 
The highest binding signals are roughly 150-fold higher than the lowest signals. Because 
the lengths of peptides used in the array are relatively short, the peptides are likely to be 
largely unstructured so that the majority interactions between antibodies and these 
surface bound peptides are not dependent on specific tertiary structures, a concept 
supported by past work comparing the binding of many different monoclonal antibodies 
to arrays of printed peptides[11]. Indeed, the binding of monoclonal antibodies to these 
dense arrays is quite diverse, with some binding observed to cognate and near-cognate 
sequences (in the case of monoclonal antibodies that recognize linear epitopes) as well as 
binding to mimitopes that bear no resemblance to the original cognate sequence.  In order 
to explore the nature of the binding of antibodies to peptide covered surfaces in more 
detail, the binding of antibody samples was monitored as a function of charge, 
hydrophobicity, length, specific amino acid contribution and position within sequence of 
the peptides in the array. 
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METHODS AND MATERIALS 
HealthTell Peptide Microarrays 
The immunosignaturing peptide microarray used in this work has been described 
previously[8]. ~330,000 peptides of near-random sequence were synthesized by light-
directed photolithography. The common linker sequence, GSG, exists on the C-terminus 
of every peptide. 152 control peptides containing the epitope“NH3-RHSVV-COOH” are 
present at random locations throughout the array. This sequence is the complete epitope 
for p53 antibody Ab1, and is a positive control.  Other partial epitopes for Ab1, Ab8 and 
DM1A are embedded into other control peptides. 
Binding Assays 
Microarrays are pre-incubated with blocking buffer (BB = 10nM Phosphate 
Buffered Saline, pH 7.3 and 05% BSA, 0.5% Tween) for 1 hour prior to addition of a 
1:20,000 dilution of serum into sample buffer (SB = BB less 0.5% Tween) for one hour 
at 25ºC.  The primary antibody is washed off with BB and then the peptide-bound 
antibodies are detected by addition of 5nM of AlexaFluor 555-conjugated anti-human 
IgG1 secondary (Rockland Antibodies, Gilbertsville, PA) for 1 hour in SB at 25ºC, then 
washed 3x in SB, then 5x in 18MOhm water followed by centrifugation at 1800g for 5 
seconds to dry.  Arrays are scanned in an Innopsys Innoscan 900 scanner at 647nm and 
555nm using high laser power and 70% PMT at 1µm resolution.  TIFF images are 
aligned with the corresponding gal file that defines which measured intensity is 
associated with which peptide feature[6]. 
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Samples 
Serum samples were received at ASU through IRB#0912004625, “Profiling 
Biological Sera for Unique Antibody Signatures”, renewed March, 2013 by the Western 
Institutional Review Board (Olympia, WA).  Monoclonals were obtained from the 
manufacturer. All disease states were assessed by SeraCare using the FDA approved 
ELISA-based diagnostic.  Monoclonals were quality checked by the manufacturer, and at 
ASU using dot-blot against peptides containing the correct epitope sequence. 
Data Analysis 
Binding signals were normalized to the mean intensity for each respective array. 
All subsequent analysis utilized the mean-normalized data. Locally written scripts in 
Matlab were used to sort the peptide sequences and to perform most of the statistical 
studies.  
RESULTS AND DISCUSSION 
Peptide binding intensity dependence on position or neighboring features 
The nature of interactions between immunoglobulins and surface bound peptides 
was explored using high density peptide arrays intentionally designed for 
immunnosignature purposes. While the peptide arrays used for this analysis have a high 
feature density, the size of each feature (8 microns diameter) is still much larger than the 
size of immunoglobulin molecules.  Thus one would expect that binding at each peptide 
feature would be independent of binding at neighboring features, unless there were issues 
associated uneven binding caused by the assay itself.  To verify binding independence of 
each peptide feature in the array, two different methods were used. The first method 
focused on the intensity of the binding signal to ‘RHSVV’ which is the epitope sequence 
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for the monoclonal antibody p53Ab1. There were 152 ‘RHSVV’ peptide features 
synthesized on the array surface at different locations.  The binding signals for both the 
P53 Ab1 monoclonal antibody and for binding of serum IgG at these peptide features was 
constant (within the noise of the measurement), regardless of the location of the peptide 
feature (data not shown). Furthermore, the binding signals for the RHSVV sequences are 
not correlated to the binding intensities observed for the neighboring peptides or to their 
physical properties (length, charge, hydrophobicity, etc.). The second method of testing 
binding equivalence across the array was more general and was applied to all peptides in 
the array. The binding intensity for each peptide sequence was plotted against the average 
binding intensity of the 6 nearest neighbor peptides surrounding it (data not shown).  This 
plot was then compared to the binding intensity for the same sequences versus the 
average binding intensity of 6 randomly selected peptides in the array. There is 
essentially no difference between two plots and the correlation between the binding for 
any particular peptide and the average binding of its neighboring peptides is very weak.  
Effect of Total Peptide Charge on IgG Binding 
Charge-charge interactions are one of the most important driving forces for 
general binding. Figure 4.1 shows the average binding signal for each sample tested as a 
function of net peptide charge at neutral pH. Typical monoclonal antibodies are slightly 
negatively charged at neutral pH. Thus, it is not surprising that both monoclonal 
antibodies (p53Ab1 and DM1A) show higher binding affinity to surface features with 
more positive charges. The effect is more pronounced for monoclonal antibody p53Ab1, 
where the average binding intensity for positively charged peptides is roughly 3.2-fold 
higher than that of negatively charged peptides. Monoclonal antibody DM1A shows a 
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much less pronounced increase at 1.2-fold. In the case of monoclonal antibodies, the 
nature of the cognate sequence and the tendency of any particular monoclonal antibody to 
bind to off-target sequences will also play a major role in dictating the charge dependence 
of binding. Interestingly, the cognate sequence of p53Ab1 (RHSVV) is itself net positive, 
consistent of what one might expect from the charge dependence of binding, while that of 
DM1A (AALEKDY) is net negative. It is interesting that DM1A on average binds more 
strongly to positively charged peptides. However, the net overall negative charge of the 
IgG molecule could be an issue.  In addition, past work has shown that p53Ab1 tends to 
be more specific for its cognate sequence and near-cognate sequences than does 
DM1A[11]. Thus, it is perhaps not surprising that the less specific monoclonal would 
have a less distinct preference with regard to the overall characteristics of the peptide, 
though it is interesting that the recognition sequence per se is not dominating the charge 
interaction.  
Two types of serum samples were tested, including 8 uninfected individuals and 8 
samples from individuals infected with Malaria.  Most of the serum samples tested show 
a similar dependence on total peptide charge, such that the average binding intensity for 
positively charged peptides is approximated 1.5 to 2-fold higher than that of negatively 
charged or neutral peptides. However, 6 serum samples from the normal group show in 
addition to the overall trend a strong preference for very highly negatively charged 
peptides (peptides with total charge -7 or -6).  This preference appears to be individual 
rather than related to infection with Malaria.  
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Figure 4.1. Average Binding Intensity as a Function of Net Charge of Peptides. The 
net charge of the peptides at neutral pH varies from -7 to +9. Intensity values shown are 
mean normalized fluorescence intensities of dye-labeled secondary antibodies captured 
by antibodies that are bound to surface bound peptides. The data shown is the average of 
all samples tested for each sample group (four sample groups: p53Ab1, DM1A, normal 
serum and malaria serum). The error bars shown represents the standard error of the 
mean for samples in the same sample group.  
Effect of peptide hydrophobicity on IgG binding 
Hydrophobic interactions are also important in driving binding interactions. 
Figure 4.2 shows the average binding signal for the monoclonal antibody and serum 
samples as a function of peptide hydrophobicity. The hydrophobicity value of each 
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peptide was estimated from the average of the hydrophobicity index values[14] for each 
amino acid in the peptide sequence. The peptides were then ranked and evenly sorted into 
12 groups, from the least hydrophobic (hydrophilic) to the most hydrophobic, according 
to their average hydrophobicity values. The effects of hydrophobicity are very similar for 
all samples. The average binding signal peaks at an average hydrophobicity value 
between -10 to 0. At the highest and lowest hydrophobicity, the binding for all samples 
decreases by more than 50% relative to the peak.  
Figure 4.2. Average Binding Intensity as a Function of Peptide Hydrophobicity. The 
binding intensities from peptides of each hydrophobicity group were averaged together. 
There were twelve hydrophobicity groups as describe in the text. Intensity values shown 
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are normalized to the mean for each sample. The data shown is the average of all samples 
tested for each sample group. The error bars shown represents the standard error of the 
mean for samples in the same sample group.  
Peptide Length Dependence 
Normally, increasing the length of a peptide would increase its chemical 
complexity. Longer peptides have a larger potential number of amino acid combinations. 
However, the way these sequences were generated, the complexity is, by one measure, 
less dependent on length.  The reason for this is that there is simply a fixed probability 
that an amino acid will be added at each particular step in the synthesis.  Thus short 
sequences end up being relatively random while longer and longer sequences have more 
in common with the sequence in which the amino acids were added.  Thus if one asks in 
a 5-mer how often an ‘A’ follows a ‘G’ or the other way around, it will be closer to 
50/50% than if one measures this for a 15-mer.  Though imperfect, this is more a measure 
of the dependence on length per se than on the order complexity of the sequences that can 
be made.  In previous studies on the binding of β-galactosidase using unbiased sequences 
of different lengths, the intensity of binding decreased as the length increasing beyond 
approximately 7 amino acids[15]. This suggested a more complex dependence of binding 
on peptide length than simply more sites to bind to, and it was suggested that this might 
have involved entropy restriction effects. Moreover, peptide length is not entirely 
independent of the net charge. For the chosen peptide sequences on the peptide arrays 
described here, longer peptides tend to be more positively charged on average. Since 
average binding intensity for positively charged peptides is higher than that of negatively 
charged or neutral peptides, one might expect that longer peptides would have higher 
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binding intensities if charge-charge interactions are dominant.  However, the situation is 
much more complex than that. Although antibodies may prefer charged motifs, the way 
these peptides were synthesized, it becomes more difficult to have any particular charged 
motif or fragment within a longer peptide sequence (again because in this approach, 
longer peptides are more biased towards the sequence in which amino acids were added). 
Thus, even though the longer peptides are more positively charged than shorter peptides, 
they may be less likely to contain certain binding sites. As seen in Figure 4.3, for serum 
samples (uninfected and malaria), the average binding signal peaked at 7 amino acids 
length and slowly dropped so that by a length of 17 amino acids the average binding is 
similar to the average binding for peptides of length 3. For monoclonal antibodies, length 
dependence is more complicated as the specific interactions with the epitope sequence are 
involved and the length of the corresponding epitope would then have large effect on the 
average binding. For p53Ab1, the length of the epitope is 5 and the average binding 
signal for p53Ab1 peaked at 5 and 6 amino acids in length. For DM1A, the small binding 
peak at length of 7 can be explained by the length of its epitope, which is 7, but the 
increase in binding at longer lengths may be because DM1A is able to take advantage of 
a wider variety of interaction sites or that binding is greater when the site is farther from 
the surface.  
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Figure 4.3. Average Binding Intensity as a Function of Length for Each Sample. The 
binding signals from peptide features of each length were averaged together. Intensity 
values shown are normalized to the mean for each sample. The data shown is the average 
of all samples tested for each sample group. The error bars shown represents the standard 
error of the mean for samples in the same sample group. 
Contribution of Specific Amino Acid Residues to Serum Binding 
Figure 4.4 shows the contribution of each amino acid to serum binding. The 
average binding intensities were calculated for peptide sequences containing the same 
amino acid. More specifically, the binding intensities from all peptides with each 
particular amino acid residue were averaged together (e.g. All peptide sequences 
possessing Alanine were averaged together to give the average binding intensity value for 
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Alanine in Figure 4.4). As seen in Figure 4.4, the average binding intensities for peptide 
sequences containing Arginine, Lysine, Proline or Glycine are ~20% higher than the 
global average binding intensity. This suggests that these amino acids may contribute to 
high binding for serum samples from both the normal and malaria groups. In contrast, the 
average binding intensities for peptide sequences containing Phenylalanine or Leucine 
are noticeably lower (more than 20% lower) than the global mean. 
 
Figure 4.4. Average Binding Intensities as a Function of Amino Acid per Peptide. 
The binding intensities from peptides with each specific amino acid residue were 
averaged together. Intensity values shown are normalized to the mean for each sample. 
The data shown is the average of all samples tested for each sample group. The error bars 
shown represents the standard error of the mean for samples in the same sample group. 
126 
Another way to look at the contribution of specific amino acids to binding would 
be by calculating the amino acid’s frequency of occurrence in the top percentage and 
bottom percentage of the binding sequences. The results show that Arginine, Lysine, 
Proline and Glycine are the most frequently occurring amino acids in the top 1% of 
binding sequences (Figure 4.5) while Phenylalanine and Leucine are the most frequently 
occurring amino acids in the bottom 1% binding sequences(Figure 4.6), consistent with 
what was shown in Figure 4.4. 
The fact that serum samples prefer amino acids with positively charged side 
chains such as Arginine and Lysine suggests the importance of charge-charge interactions 
in serum-peptide binding on the surface. Although serum contains a large number of 
different biomolecules, the measured binding signals are specifically from IgG molecules 
and peptides, in part because at the high dilution used only antibodies have small enough 
dissociation constants to remain bound, and also because the binding is detected with 
fluorescently labeled anti-human-IgG. Because the pI of IgG molecules is slightly lower 
than neutral pH, this may promote electrostatic forces and long-range interactions with 
positively charge amino acid side chains. In addition, the amino acids contributing to 
high binding intensities here are significantly different from amino acids preferred by the 
general antibody-epitope interfaces[16, 17]. This suggests that the interactions between 
serum IgG and surface-bound peptides here may not be driven entirely by specific 
antibody-antigen interactions; instead, interactions driven by general forces may also play 
a key role.  
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Figure 4.5. A heatmap of the frequency of occurrence of specific amino acids in the 
top 1% serum binding sequences. Each column represents a different amino acid used.  
Each row represents a different sample tested (ND represents normal sample and MA 
represents malaria sample). The color represents the frequency of occurrence of a 
particular amino acid in the highest 1% binding sequences.  A color value of 0.06 
represents a frequency of occurrence of a particular amino acid equivalent of that 
expected from a randomly defined sequence (1/16 since there are 16 different amino 
acids used). 
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Figure 4.6. A heatmap of the frequency of occurrence of specific amino acids in the 
bottom 1% serum binding sequences. Each column represents a different amino acid 
used.  Each row represents a different sample tested (ND represents normal sample and 
MA represents malaria sample). The color represents the frequency of occurrence of a 
particular amino acid in the lowest 1% binding sequences.  A color value of 0.06 
represents a frequency of occurrence of a particular amino acid equivalent of that 
expected from a randomly defined sequence (1/16 since there are 16 different amino 
acids used). 
Effect of Amino Acid Position within a Peptide Sequence 
Amino acid position within a peptide sequence was also considered. A 16 (amino 
acid name) by 17 (amino acid position number, position 1 is N-terminus and position 17 
is C-terminus for a peptide with 17 amino acid residues) matrix was created to examine 
the effect of amino acid position on binding. For each amino acid, the binding intensities 
for all peptides with the amino acid at the same position were averaged together and 
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plotted against the amino acid position relative to the N-terminus (Figure 4.7). Generally, 
the effect on binding of the specific amino acid used is not very dependent on where the 
amino acid is placed within a peptide. But the position of some amino acids has bigger 
effect on binding than that of others. For example, the contribution of glycine and proline 
to the strong binding signals was ~50% higher when they are near the N-terminus 
compared to the C-terminus, whereas the contribution of lysine remains the roughly 
same. In general, the effect of an amino acid identity is less significant toward C-
terminus. Note however that the position number is defined as the position of an amino 
acid relative to N-terminus. Because the length of peptides are range from 3 to 17 amino 
acids, there are fewer and fewer peptides at any given position as one progresses from the 
N to C terminus.  
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Figure 4.7. Average Binding Intensity as a function of amino acid position within a 
peptide sequence for each amino acid. The sample used for creating this figure is ND-
151, other samples give very similar binding trends (Figures not shown). For each amino 
acid, the binding intensities for peptides with such amino acid at the same position were 
averaged together. Intensity values shown are normalized to the mean value.  
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CHAPTER 5: CONCLUSIONS AND FUTURE CONSIDERATIONS 
The interaction of proteins with chemically complex surfaces is of critical 
significance in both biological and man-made systems. A complete understanding of the 
protein-surface interactions is useful because it will potentially tell us how proteins 
function in many biological processes involving cellular interfaces and contribute to 
developing surfaces with selective binding or nonbinding properties for practical use. Up 
to this time, the majority of the studies on molecular interactions have mainly focused on 
specific interactions with well-defined final complexes. In contrast, interactions that do 
not result in a unique structure for the final complex are usually considered nonspecific 
and treated as a nuisance to experiments. However, as described in chapter 1, 
unstructured interactions are more ubiquitous in the cellular environments and participate 
in many biological processes. Therefore, there is a need to characterize and further study 
these interactions. In fact, the strength of either type of interactions largely comes from 
long-range forces such as general charge-charge interactions (examples include DNA 
binding proteins, antigen-antibody interactions). While for a specific interaction, the final 
structure is defined by interactions like specific hydrogen bonds or short-range van der 
Waals forces and the affinity depends on the goodness of fit between the interacting 
surfaces; for an unstructured interaction or so called nonspecific interaction, the affinity 
is driven by longer range forces only or by a summation of many interactions that allow a 
set of heterogeneous binding structures instead of stabilizing one particular binding 
structure. 
It is difficult to detect and characterize unstructured interactions with 
conventional techniques.  As mentioned in Chapter 1, most existing approaches to study 
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molecular interactions are trying to search and characterize the most favored single 
structure among all the complexes formed. This makes these approaches not suitable for 
studying the unstructured interactions because an unstructured interaction does not have a 
predominant binding structure, instead, a variety of low affinity structures that are equally 
important are often formed in one interaction. The research projects in this dissertation 
demonstrated a statistical approach to study molecular interactions, including both 
structured and unstructured interactions, between proteins and heterogonous surfaces 
covered with peptides. Unlike most classical approaches for studying molecular 
interactions, this approach does not force the system to converge on a single binding 
structure; instead, it allows systematic analysis of binding to diverse arrays with a large 
number of potential binding partners and uses the binding information to understand the 
chemistry of molecular interactions at surfaces.  
Chapter 2 described the binding of β-galactosidase, α1-antitrypsin and a protein 
mixture with a set of 9 different soluble proteins to the LC Sciences array surface-
attached peptides from a library, covering lengths from 2 to 12 amino acids and sequence 
permutations of 7 amino acids {E, L, S, R, Q, W, Y}, representing a broad span of 
overall charge and hydrophobicity. In spite of apparently unstructured interactions of the 
immobilized peptides with the proteins of interest, the interactions can be quiet strong 
and diverse. In addition, considerable selectivity of protein binding to the peptide-coated 
surface can be obtained. The work presented in Chapter 2 supports the concept that 
specific and nonspecific binding are better thought of as two ends of amore continuous 
spectrum and suggests the possibility of creating surfaces covered with short peptide 
sequences with relative specific protein interaction profiles. However, due to the 
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limitations associated with LC Sciences PepArray platform (e.g. cost, lack of controls on 
binding experiments, etc), although the work was able to demonstrate the possibility of 
using peptide arrays in exploring the interaction space of proteins with complex surfaces, 
additional experiments are required to fully understand the concepts. For example, a 
larger number of additional individual proteins with different physicochemical properties 
and of different origin could be tested with the same surface and compare to the binding 
profiles of β-galactosidase and α1-antitrypsin. This would allow a more extensive study 
on the correlation between the binding profile and the protein physicochemical 
properties. For instance, the correlation between the binding profile and the protein 
isoelectric point could be examined. Similarly, the hydrophobicity of the proteins can be 
taken into account by using the accessible area of hydrophobic amino acid residues. This 
can further verify the driving forces for unstructured surface interactions and how they 
contribute to discriminating proteins. In addition, the binding experiments could be 
performed at variable pH and ionic strength, to estimate relative contributions of 
electrostatic forces and hydrophobic interactions into the surface peptide-protein binding 
capacity. Another interesting question is whether using a larger subset of amino acids as 
building blocks would change the correlation between surface binding and peptide 
sequence properties. Creating a peptide library using an increased amino acid alphabet 
size would increase the chemical complexity represented by the library, though a smaller 
percentage of the full sequence space would be covered and used for the statistical study.   
Since short surface-bound peptides can have both strong and selective interactions 
with proteins, one interesting fundamental question to ask is how addition or combination 
of short peptide sequences change the properties of a surface covered with a particular 
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short peptide. The answers to these questions are very important for developing the 
principles needed to engineer new surfaces with specific properties using relatively short 
peptides. The strategy employed in Chapter 3 for preparing peptide arrays, which 
involved the use of selected tetrapeptides with known binding characteristics to β-
galactosidase as C-terminal bases tethered to the surface, and either an N-terminal 
extension by one, two or three amino acids, or a concatenation with another tetrapeptide, 
were designed to answer these questions. One of the most important observations is that 
while both additions and combinations of short peptide sequences can either greatly 
increase or decrease the binding and relative specificity of a particular tetrapeptide on the 
surface, the contribution to the binding affinity and relative specificity of the individual 
binding components is strongly dependent on their position within the peptide sequence. 
Moreover, component sequences that bind strongly at the C-terminus of the peptide do 
not necessarily add substantially to binding and specificity when placed at the N-
terminus. It is important to note that although a surface covered with random-sequence 
peptides with longer lengths may possess similar or even higher chemical complexity and 
degree of differential binding, short peptides are easier and cheaper to use for surface 
modification.   
 Due to the limitations associated with LC Sciences arrays, it would be useful to 
perform similar studies with a different array system. As described in Chapter 1, the 
HealthTell array system is another array platform that is completely different from the 
LC Sciences array system. HealthTell Arrays are in a different format and are built on a 
different substrate. These arrays are developed for the purpose of performing 
immunosignature diagnostics, which attempts to identify a unique binding pattern of 
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circulating antibodies in serum that differentiates healthy individuals from those with a 
particular disease. In chapter 4, fundamental questions about general interactions between 
antibodies and peptide attached to surfaces are answered by systematically studying the 
binding of monoclonal antibodies and serum to the HealthTell array surface covered with 
particular peptides, from a library consisting of ~330,000 peptide sequences with a length 
range from 3 to 17 amino acids and amino acid alphabet size of 16 (cysteine, methionine, 
isoleucine and threonine were excluded). The peptide sequences include certain epitope 
sequences and random sequences that are not derived from any natural binding sequence 
space. While it is confirmed that the linear epitopes can be recognized and specifically 
targeted upon binding to the antibodies, the random sequences may or may not behave 
the same. The interactions driven by general forces may play an important role in 
peptide-surface binding with HealthTell array system. Consistent with what was seen 
before, the interactions can be strong and diverse. Effects of charge, hydrophobicity, 
length and amino acid position on IgG binding on HealthTell array surface are quiet 
similar to what was observed with β-galactosidase on LC Science array surface. This 
suggests that general interactions play a role in addition to any cognate-type binding. In 
addition, positively charged amino acids are preferred by serum samples further 
confirming the importance of general electrostatic interactions in serum binding on 
surfaces.  
 To further study the general interactions between antibodies and the HealthTell 
array surface, a number of other sequence properties of surface-bound peptides can be 
examined and correlated to the binding of antibodies to the surfaces. For example, 
sequence complexity, flexibility and accessibility can be considered. These studies may 
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provide information on the entropic cost upon binding. Also, the binding assays could be 
performed at a variable pH and instead of looking at the total charge for each peptide at 
neutral pH, the isoelectric point could be considered. It may also worthwhile to look at 
the correlation between binding and the position of certain tetrapeptides within a 
sequence. Although it has been shown that the binding is not strongly dependent on the 
position of any single amino acid within the sequence, position of tetrapeptides or longer 
binding units within a sequence might still be important (As in Chapter 3, single amino 
acid position is not important but the tetrapeptide position is important in term of the 
contribution to binding).    
In summary, unstructured affinity driven by multiple weak interactions plays an 
important role in many biological processes. As our understanding of the crowded 
environment of the cell increases, it has become more and more apparent how important 
controlling such interactions is.  Although still in early stages, this dissertation work 
demonstrates the possibility of using peptide arrays in exploring the interaction space of 
proteins with surfaces. With the technology advancing and expanding rapidly, there is 
tremendous space to explore many more studies with this approach, and we could expect 
a brand new way to create complex surfaces for our use.   
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